<SEC-DOCUMENT>0001213900-23-067848.txt : 20230815
<SEC-HEADER>0001213900-23-067848.hdr.sgml : 20230815
<ACCEPTANCE-DATETIME>20230815170017
ACCESSION NUMBER:		0001213900-23-067848
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230809
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230815
DATE AS OF CHANGE:		20230815

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Courtside Group, Inc.
		CENTRAL INDEX KEY:			0001940177
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
		IRS NUMBER:				352503373
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-269028
		FILM NUMBER:		231175629

	BUSINESS ADDRESS:	
		STREET 1:		335 NORTH MAPLE DRIVE
		STREET 2:		#127
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90210
		BUSINESS PHONE:		310-858-0888

	MAIL ADDRESS:	
		STREET 1:		335 NORTH MAPLE DRIVE
		STREET 2:		#127
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90210

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Courtside Group, Inc
		DATE OF NAME CHANGE:	20220727
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea183613-8k_courtside.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:podc="http://courtsidegroupinc.com/20230809">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_033_podc_courtsidegroupinc.com_20230809 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20230809_20230809 -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0001940177 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2023-08-09" name="dei:EntityCentralIndexKey">0001940177</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2023-08-09" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="podc-20230809.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2023-08-09">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001940177</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-09</xbrli:startDate>
        <xbrli:endDate>2023-08-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90B_edei--DocumentType_c20230809__20230809_zuZ7RAIKzR2"><ix:nonNumeric contextRef="AsOf2023-08-09" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_905_edei--DocumentPeriodEndDate_c20230809__20230809_zwhvxgZRqx39"><ix:nonNumeric contextRef="AsOf2023-08-09" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">August 9, 2023</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_902_edei--EntityRegistrantName_c20230809__20230809_zhQ9cx0s579k"><ix:nonNumeric contextRef="AsOf2023-08-09" name="dei:EntityRegistrantName">COURTSIDE GROUP, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20230809__20230809_zgfn8PrRhWQ4"><ix:nonNumeric contextRef="AsOf2023-08-09" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityFileNumber_c20230809__20230809_zkaYmpY8MHX9"><ix:nonNumeric contextRef="AsOf2023-08-09" name="dei:EntityFileNumber">333-269028</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityTaxIdentificationNumber_c20230809__20230809_zRRVcw5be4af"><ix:nonNumeric contextRef="AsOf2023-08-09" name="dei:EntityTaxIdentificationNumber">35-2503373</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction<br />
of incorporation)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission File&#160;Number)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer<br />
Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_903_edei--EntityAddressAddressLine1_c20230809__20230809_zN9cLykZ9Q63"><ix:nonNumeric contextRef="AsOf2023-08-09" name="dei:EntityAddressAddressLine1">335 N. Maple Drive Suite 127</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_90E_edei--EntityAddressCityOrTown_c20230809__20230809_zBZoSNse99k"><ix:nonNumeric contextRef="AsOf2023-08-09" name="dei:EntityAddressCityOrTown">Beverly Hills</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressStateOrProvince_c20230809__20230809_zXomHH6yVgo9"><ix:nonNumeric contextRef="AsOf2023-08-09" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span> <span id="xdx_908_edei--EntityAddressPostalZipCode_c20230809__20230809_zNgkWL9d1tu8"><ix:nonNumeric contextRef="AsOf2023-08-09" name="dei:EntityAddressPostalZipCode">90210</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">(<span id="xdx_907_edei--CityAreaCode_c20230809__20230809_zA5Q0EmtpCP1"><ix:nonNumeric contextRef="AsOf2023-08-09" name="dei:CityAreaCode">310</ix:nonNumeric></span>)&#160;<span id="xdx_90E_edei--LocalPhoneNumber_c20230809__20230809_zC6NQAkRAffk"><ix:nonNumeric contextRef="AsOf2023-08-09" name="dei:LocalPhoneNumber">858-0888</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">n/a</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--WrittenCommunications_c20230809__20230809_zrHbrKqWbhWe"><ix:nonNumeric contextRef="AsOf2023-08-09" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--SolicitingMaterial_c20230809__20230809_zLllqhikikI2"><ix:nonNumeric contextRef="AsOf2023-08-09" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--PreCommencementTenderOffer_c20230809__20230809_zGRvef6yGjw8"><ix:nonNumeric contextRef="AsOf2023-08-09" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--PreCommencementIssuerTenderOffer_c20230809__20230809_z2FkF9DmWjjj"><ix:nonNumeric contextRef="AsOf2023-08-09" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Securities registered
pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of each class</span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Securities registered pursuant to Section
12(g) of the Act: None</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company <span style="background-color: white"><span id="xdx_90D_edei--EntityEmergingGrowthCompany_c20230809__20230809_zjhfS3YGVWy3"><ix:nonNumeric contextRef="AsOf2023-08-09" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_902_edei--EntityExTransitionPeriod_c20230809__20230809_zaRgVbcfWotl"><ix:nonNumeric contextRef="AsOf2023-08-09" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1.01 Entry Into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">The information set forth
in Item 5.02 below is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 3.02 Unregistered
Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The information set forth
in Item 5.02 below is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 5.02 Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Employment Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On August 9, 2023 and effective
as of January 1, 2023 (the &#8220;Effective Date&#8221;), Courtside Group, Inc. (the &#8220;Company&#8221;) entered into a new employment
agreement with Sue McNamara, the Company&#8217;s current Chief Revenue Officer (the &#8220;Employment Agreement&#8221;). The term of the
Employment Agreement is for two years from the Effective Date at an annual salary of $325,000. Ms. McNamara is eligible to earn an annual
fiscal year performance bonus for each whole or partial fiscal year of her employment period with the Company in accordance with the Company&#8217;s
ABP (as defined below) applicable to the Company&#8217;s executive officers and other employees and expected to be approved by the Company&#8217;s
board of directors (the &#8220;Board&#8221;). Ms. McNamara&#8217;s &#8220;target&#8221; performance bonus shall be 100% of her average
annualized base salary during the fiscal year for which the performance bonus is earned. Pursuant to the Employment Agreement, Ms. McNamara
was granted: (i) 125,000 restricted stock units of the Company (the &#8220;Company RSUs&#8221;), and (ii) 75,000 restricted stock units
of LiveOne, Inc. (&#8220;LiveOne&#8221;), the Company&#8217;s parent (the &#8220;LiveOne RSUs&#8221; and together with the Company RSUs,
the &#8220;RSUs&#8221;). The Company RSUs were granted pursuant to the Company&#8217;s 2022 Equity Incentive Plan (the &#8220;Company
EIP&#8221;), and the LiveOne RSUs were granted pursuant to LiveOne&#8217;s 2016 Equity Incentive Plan, as amended. 50% of the RSUs shall
vest on the one year anniversary of the Effective Date (the &#8220;Initial Vesting Date&#8221;), and the remaining 50% of the RSUs shall
vest on the two year anniversary of the Effective Date (the &#8220;Subsequent Vesting Date&#8221; and together with the Initial Vesting
Date, the &#8220;Vesting Dates&#8221;), subject to Ms. McNamara being continuously employed by and being in good standing with the Company
and the Employment Agreement being in effect, in each case through each applicable Vesting Date (except as provided below). Each vested
Company RSU shall be settled by delivery to Ms. McNamara of one share of the Company&#8217;s common stock promptly following the applicable
Vesting Date (a &#8220;PC1 Settlement Date&#8221;). Each vested LiveOne RSU shall be settled by delivery to Ms. McNamara of one share
of LiveOne&#8217;s common stock promptly following the applicable Vesting Date (except as provided below). If at the time of a PC1 Settlement
Date, the Company has not completed the Going Public Transaction (as defined below), the Company agreed to cause LiveOne to issue to Ms.
McNamara, in lieu of the Company&#8217;s common stock that would be issued upon the settlement of any Company RSUs that would vest on
such PC1 Settlement Date, such number of shares of LiveOne&#8217;s common stock for each vested Company RSU as would equal to a one to
one ratio. After any settlement of any vested Company RSUs, the remaining unvested Company RSUs shall be settled in the Company&#8217;s
common stock, subject to the terms of the Employment Agreement. &#8220;Going Public Transaction&#8221; means the earlier of (i) the date
on which the Company consummates the direct listing of its common stock on a national stock exchange and (ii) the date of completion of
any other transaction by the Company as a result of which the Company&#8217;s common stock is listed on a national stock exchange.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the event a PC1 Change
of Control (as defined in the Employment Agreement), if Ms. McNamara remains employed by the Company through the date of such PC1 Change
of Control, 50% of then unvested Company RSUs shall vest in full effective immediately prior to such event. In the event a LVO Change
of Control (as defined in the Employment Agreement), if Ms. McNamara remains employed by the Company through the date of such LVO Change
of Control, 50% of then unvested LiveOne RSUs shall vest in full effective immediately prior to such event. The RSUs grants will be evidenced
by a standard form of the Company&#8217;s or LiveOne&#8217;s restricted stock units award agreement, as applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If Ms. McNamara&#8217;s employment
is terminated by the Company without &#8220;Cause&#8221; or by Ms. McNamara for &#8220;Good Reason&#8221; (each as defined in the Employment
Agreement, subject to the Company&#8217;s right to cure), she will be entitled to termination benefits, pursuant to which the Company
will be obligated to (i) pay Ms. McNamara certain accrued obligations and to continue to pay Ms. McNamara her base salary for a period
that is the lesser of (x) 6 months from the effective termination date and (y) the remaining period of the term of her Employment Agreement,
and (ii) accelerate the vesting of 100% of any unvested RSUs and any other equity awards granted by the Company. The foregoing termination
benefits are subject to Ms. McNamara&#8217;s delivery to the Company of an executed release of claims against it and continued compliance
with her confidentiality agreement with the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Employment Agreement
contains covenants for the benefit of the Company relating to non-interference with the Company&#8217;s business after termination of
employment and protection of the Company&#8217;s confidential information, certain customary representations and warranties and standard
Company indemnification obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="background-color: white">The
foregoing description of the Employment Agreement does not purport to be complete and is qualified in its entirety by reference to the
full text of such agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K (this &#8220;Current Report&#8221;) and
is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The shares of the Company&#8217;s
common stock and LiveOne&#8217;s common stock underlying the RSUs may be issued, if any, in a private placement that will rely upon an
exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;),
and/or Regulation D promulgated thereunder, or pursuant to the Company&#8217;s Registration Statement on Form S-8, if and when such is
filed by the Company with the U.S. Securities and Exchange Commission, or LiveOne&#8217;s Registration Statement on Form S-8, as applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white"><i>Annual Bonus Plan</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">Effective
as of the Effective Date, the Company adopted the 2023 Annual Bonus Plan (the &#8220;ABP&#8221;), which shall be subject to the approval
of the Board or its compensation committee. Any bonuses that may be earned under the ABP shall be tied to the financial performance of
the Company and the price of the Company&#8217;s common stock for the Company&#8217;s applicable fiscal year. The ABP will be administered
by a committee (the &#8220;Committee&#8221;) consisting of the following three current executives of the Company as of the date of the
ABP: Kit Gray, the Company&#8217;s President, Robert S. Ellin, the Company&#8217;s Executive Chairman and a director, and Aaron Sullivan,
the Company&#8217;s Interim Chief Financial Officer. If for any reason any such Committee member shall be removed or is no longer serving
on the Committee, the Board shall appoint a replacement member of the Committee that will be an executive officer of the Company with
direct ties to the Company&#8217;s operations. The ABP provides the Company&#8217;s employees and executive officers (the &#8220;Participants&#8221;)
with the opportunity to earn annual incentive compensation awards based upon the achievement of certain pre-determined performance measures
during the applicable performance period. Such performance measures may differ among Participants and awards, may be in terms of Company-wide
and/or individual objectives, and may include a variety of quantitative and/or qualitative metrics as set forth in the ABP and as determined
by the Committee, which may include, among others, the Company&#8217;s revenue, adjusted EBITDA, stock price and the achievement of such
other Company key operating metrics and such other objectives as the Committee determines, each with a specified weighting as determined
by the Committee based on the recommendation of the Company&#8217;s President, subject to the Board&#8217;s or its compensation committee&#8217;s
final approval of the applicable performance goals for the Company for each applicable fiscal year, the cash versus equity split of such
awards and the amount of any such awards. All incentive awards payable under the ABP will be paid in cash or in the form of equity issued
by the Company under the Company EIP, or both.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">The
Committee will have the discretion to increase, reduce, or eliminate an incentive award that would otherwise be payable to one or more
Participants on the basis of the certified level of attained performance. Unless the Committee determines otherwise and subject to certain
exceptions, no Participant will have any right to receive payment of an award under the ABP for a performance period unless the participant
remains employed with the Company through the last business day of the applicable fiscal year. Awards under the APB may be granted to
Participants selected by the Committee in its sole discretion; provided, that the Company&#8217;s President, Chief Revenue Officer and
Chief Content Officer shall be mandatory Participants under the ABP. The Committee may at any time amend, suspend or terminate the ABP,
and subject to the approval of the Board. Subject to the approval of the ABP by the Board, the ABP contains target and maximum potential
payouts, which are based on the Company reaching certain predetermined performance targets and will be in the form of cash and equity
of the Company, and the applicable performance measures for the applicable fiscal years ending March 31, 2024 and 2025 (the &#8220;Fiscal
Years&#8221;), and which targets may be adjusted based on individual objectives. The ABP further provides that in no event shall the actual
bonuses payable under the ABP to all Participants for the applicable Fiscal Year exceed in the aggregate the dollar amount provided in
the ABP, as may be subsequently adjusted by its terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="background-color: white">The
foregoing description of the ABP does not purport to be complete and is qualified in its entirety by reference to the full text of the
ABP, which is filed as Exhibit 10.2 to this Current Report and is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b></b></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 9.01 Financial
Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">(d)
Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 9%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br />
Number</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCECFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1&#8224;</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea183613ex10-1_courtside.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement, dated August 9, 2023, between the Company and Sue McNamara.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: transparent">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2&#8224;</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea183613ex10-2_courtside.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company&#8217;s 2023 Annual Bonus Plan.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104&#160;</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">&#8224;</td><td style="text-align: justify">Indicates a management contract or compensatory plan.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Filed herewith.</td>
</tr></table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COURTSIDE GROUP, INC.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: August 15, 2023</span></td>
    <td style="width: 5%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </span></td>
    <td style="border-bottom: black 1.5pt solid; width: 35%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/&#160;<i>Aaron Sullivan</i></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aaron Sullivan</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim Chief Financial Officer </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">4</p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5Fk2rBe2bFhWxihQRX6PdSrDNlk38O5K3NLaIy8KyzHwzQvTEkha6QobjLM9gj3VTKYeQY4mM5ozeka7WCfib40Vbx8q49v2BKXkGPRP3w8nJC631ri0WCcjxIIwH0RDkKJExTDci+OopmVIXaJxWFShTwI6pYY1O8atL2KsnGapfbdUB2WoyCYR92clviGQYwZbu6kF8tZBlqQh67QRiyXRrvjU366iGeYW177Id+t/gAxYJSUQ= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ea183613ex10-1_courtside.htm
<DESCRIPTION>EMPLOYMENT AGREEMENT, DATED AUGUST 9, 2023, BETWEEN THE COMPANY AND SUE MCNAMARA
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Courtside Group, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">335 N. Maple Drive, Suite 127<BR>
Beverly Hills, CA 90210</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-align: right; text-indent: 0.5in">August 9, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ms. Sue McNamara<BR>
235 E. 22nd St., Apt 16F</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, NY 10010</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Sue:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This letter sets forth the
agreement (this &ldquo;Agreement&rdquo;), dated as of the date set forth above and effective as of January 1, 2023 (the &ldquo;Effective
Date&rdquo;), by and between Courtside Group, Inc. (dba Podcast One) (&ldquo;Company&rdquo;) and you (&ldquo;Executive&rdquo;) with respect
to Executive&rsquo;s engagement by Company to render services as more specifically set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Engagement</U>:
Company wishes to employ Executive as its Chief Revenue Officer (&ldquo;CRO&rdquo;). In connection therewith, Executive shall report directly
to Company&rsquo;s Executive Chairman and Company&rsquo;s President, or such other person as designated by Company&rsquo;s board of directors
(the &ldquo;Board&rdquo;). Executive&rsquo;s principal place of business will be in New York, New York, including a remote work arrangement.
Executive shall travel to Company&rsquo;s other offices as Company and/or LiveOne, Inc. (a Delaware corporation and Company&rsquo;s parent)
(&ldquo;LiveOne&rdquo;) shall maintain from time to time, as required to perform her services hereunder or as reasonably required by Company
or LiveOne, at Company&rsquo;s expense (comfort plus travel and accommodations) and in accordance with the generally applicable policies
and procedures of Company, subject to presentation of reasonably detailed expense statements or vouchers and such other information as
Company may reasonably require. As a condition of employment, Executive shall execute and comply with the Confidentiality, Non-Interference
and Invention Assignment Agreement attached hereto as <U>Exhibit A</U> (&ldquo;Confidentiality Agreement&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Term</U>:
Executive shall be employed for a period of two (2) years, commencing on the Effective Date and ending on and inclusive of the second
(2<SUP>nd</SUP>) anniversary of the Effective Date, unless terminated earlier pursuant to paragraph 6 of this Agreement (the &ldquo;Term&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Compensation</U>:
(a) <U>Salary</U>. During the Term, Company shall pay to Executive a cash base salary of $325,000 per annum starting on the
Effective Date and continuing until end of the Term (the &ldquo;Base Salary&rdquo;). During the Term, the Board (or the Compensation
Committee thereof) shall review the Base Salary not less frequently than on an annual basis and may increase (but not decrease,
including as it may be increased from time to time) the Base Salary. Company shall pay the Base Salary to Executive in accordance
with the Company&rsquo;s generally applicable payroll practices for Company&rsquo;s executive officers (the &ldquo;Executive
Officers&rdquo;), but not less frequently than in equal biweekly installments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)  <U>Bonus</U>.
In addition to the base salary, Executive is eligible to earn an annual fiscal year performance bonus (a &ldquo;Performance Bonus&rdquo;)
for each whole or partial fiscal year during the Term, beginning on April 1, 2023, in accordance with Company&rsquo;s annual bonus plan
applicable to the Company&rsquo;s executive officers, substantially the form of <U>Exhibit B</U> attached hereto (the &ldquo;Annual Bonus
Plan&rdquo;), which Annual Bonus Plan is expected to be adopted by Board after the date hereof. (The Company&rsquo;s fiscal year, as of
the Effective Date, shall be April 1 to March 31.) Executive&rsquo;s &ldquo;target&rdquo; Performance Bonus shall be up to one hundred
percent (100%) of Executive&rsquo;s average annualized base salary during the fiscal year for which the Performance Bonus is earned. Executive&rsquo;s
&ldquo;target&rdquo; Performance Bonus is referred to herein as the &ldquo;Target Bonus.&rdquo; The award of any Performance Bonus (or
Target Bonus) shall be subject to the determination of the Bonus Committee (as defined in <U>Exhibit B</U>) of the amount of the Performance
Bonus amount (not to exceed the maximum Target Bonus as set forth in <U>Exhibit B</U>) and approval of the Performance Bonus amount by
the Board, based on the Company meeting or exceeding major milestones set forth on <U>Exhibit B</U> for each whole or partial fiscal year
of the Company during the Term beginning on April 1, 2023 (collectively, the &ldquo;Bonus Target Objectives&rdquo;). The Performance Bonus
(or Target Bonus) shall be paid to Executive in cash and/or in shares of the Company Common Stock (as defined below) with percentages
as set forth in <U>Exhibit B</U>, at the sole discretion of the Board depending on the financial condition of the Company. The Company
agrees that the Bonus Target Objectives will be no less favorable in the aggregate to Executive than the objectives established and used
under the Annual Bonus Plan to determine the amount of the annual bonus payable to the other senior executive officers of the Company,
such as the President, Chief Content Officer or Chief Operating Officer (&ldquo;Executive Officers&rdquo;) who participate in the Annual
Bonus Plan; provided, that the Bonus Committee may determine the breakdown of the specific Performance Bonus objectives based on the terms
of Bonus Plan. Except as otherwise provided herein: (i) depending on such performance in any particular whole or partial fiscal year,
and on the criteria set forth in the Annual Bonus Plan, the actual amount of the Performance Bonus for that fiscal year may be less than,
equal to, or greater than the Target Bonus; (ii) Company shall pay each Performance Bonus to Executive at the same time that annual cash
bonuses are paid to the other Executive Officers, but in no event later than the fifteenth (15<SUP>th</SUP>) day of the third month following
the end of the applicable fiscal year for which the Performance Bonus is earned; (iii) Executive shall be eligible to earn a Performance
Bonus from the beginning of the fiscal year on April 1, 2023 and ending on March 31, 2024, and from the beginning of the fiscal year on
April 1, 2024 and ending on December 31, 2024; and (iv) Executive shall be entitled to receive, and shall receive any Performance Bonus
(or pro rata thereof) earned and awarded, if any, even if Executive is not employed on the date on which annual bonuses for the applicable
fiscal year are paid (or are payable in accordance with this Section 5.2), so long as Executive earned such Performance Bonus during the
fiscal year while Executive was actually employed. For clarity, this Section 3(b)(iii) means that if, at the end of Term, Executive&rsquo;s
employment with the Company is not renewed for any reason, Executive shall still receive Executive&rsquo;s Performance Bonus earned and
awarded, if any, up to the date of Executive&rsquo;s separation from Company, regardless of whether Executive is employed by the Company
on the date when cash and stock bonuses for the applicable fiscal year are paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)  <U>Equity
Grant</U>. (i) Subject to approval by the Board, and the Company completing the Going Public Transaction (as defined below), the Company
shall grant to Executive, as soon as practicable following the Effective Date, but no later than thirty (30) days following the date of
this Agreement, an initial equity grant (the &ldquo;PC1 Equity Grant&rdquo;) consisting of: one hundred and twenty-five thousand (125,000)
restricted stock units of the Company (the &ldquo;PC1 RSUs&rdquo;). The PC1 Equity Grant shall be made under the Company&rsquo;s 2022
Equity Incentive Plan (as amended, modified or restated from time to time, the &ldquo;2022 PC1 EIP&rdquo;) and will be evidenced by the
Company&rsquo;s standard form of Award Agreement (as defined in the 2022 PC1 EIP) between Executive and the Company (the &ldquo;PC1 Award
Agreement&rdquo;). Subject to Section 6, the PC1 RSUs shall vest as follows: (i) 50% of the RSUs shall vest twelve (12) months from the
Effective Date (the &ldquo;Initial Vesting Date&rdquo;), and (ii) the remaining 50% of the RSUs shall vest twenty-four (24) months from
the Effective Date (the &ldquo;Subsequent Vesting Date&rdquo; and together with the Initial Vesting Date, each a &ldquo;Vesting Date&rdquo;
and collectively, the &ldquo;Vesting Dates&rdquo;), provided that for each PC1 RSUs vesting tranche, Executive is continuously employed
by and is in good standing with the Company and this Agreement is in effect, in each case through each applicable Vesting Date (except
as otherwise provided in Section 6). Notwithstanding the foregoing or anything herein to the contrary, if Executive remains employed through
the date of a PC1 Change of Control (as defined below), 50% of Executive&rsquo;s then-unvested PC1 RSUs shall vest in full effective immediately
prior to such PC1 Change of Control. Each respective vested PC1 RSU shall be settled by delivery to Executive of one share of the Company&rsquo;s
common stock, $0.00001 par value per share (the &ldquo;Company Common Stock&rdquo;), per vested PC1 RSU promptly after the applicable
Vesting Date (each such applicable date, the &ldquo;PC1 Settlement Date&rdquo;). Upon and after each PC1 Settlement Date, the Company
may in its sole discretion (but shall have no obligations whatsoever to do so), and to the extent permissible under applicable law and
the Company&rsquo;s Insider Trading Policy, allow Executive to satisfy her tax obligations arising in connection with the settlement of
her vested PC1 RSUs through the sale by her in the open market of a number of shares of Company Common Stock underlying the vested and
settled PC1 RSUs up to the maximum amount that would be sufficient to pay the amount of those tax obligations. Notwithstanding the foregoing,
if at the time of a PC1 Settlement Date, the Company has not completed the Going Public Transaction, Company agrees that in lieu of Company
Common Stock that would be issued upon the settlement of any PC1 RSUs that would vest on such PC1 Settlement Date, LiveOne shall issue
Executive such number of shares of LVO Common Stock for each vested PC1 RSU (the &ldquo;Exchange&rdquo;) as would equal to a ratio of
125,000 divided by 125,000, and executive shall have the right to satisfy his tax obligations in connection with such settlement through
the sale of LVO Common Stock in accordance with the terms of Section 3(c)(ii), and Company agrees to cause LiveOne to comply with the
foregoing requirements. For the avoidance of doubt, after any settlement of any vested PC1 RSUs, the remaining unvested PC1 RSUs shall
be settled in Company Common Stock, subject to the terms of this Agreement, including the foregoing sentence and the Exchange, if applicable.
&ldquo;PC1 Change of Control&rdquo; shall have the meaning of &ldquo;Change of Control&rdquo; provided in the 2022 PC1 EIP, except that
(i) for purposes of determining whether a PC1 Change of Control has occurred under this Agreement, (x) the acquisition of additional shares
of PC1 Common Stock or LVO Common stock (as defined below) and/or convertible or voting securities of the Company or LiveOne, as applicable,
by Robert Ellin, LiveOne and/or their Affiliates (as defined below) resulting in LiveOne, Mr. Ellin and/or their respective Affiliates
having Beneficial Ownership (as such term is defined in the Exchange Act) of more (or less) than 50% of the total voting power of the
stock of the Company or LiveOne will not be considered a PC1 Change of Control, and (y) the disposition, transfer, conveyance or sale
of shares of PC1 Common Stock and/or convertible or voting securities of the Company by Robert Ellin, LiveOne and/or their Affiliates
will not be considered a PC1 Change of Control (other than as a result of any Additional PC1 Change of Control (as defined below)), (ii)
for purposes of the PC1 RSUs (and any other amounts payable on a PC1 Change of Control that constitute &ldquo;nonqualified deferred compensation&rdquo;
within the meaning of Section 409A), a PC1 Change of Control shall only be deemed to occur if such transaction also constitutes a &ldquo;change
of control event&rdquo; within the meaning of Section 409A; and (iii) notwithstanding clause (i), a consummation of a transaction described
on <U>Exhibit C</U> attached hereto will not be considered a PC1 Change of Control. &ldquo;Additional PC1 Change of Control&rdquo; means
the occurrence after the date of this Agreement of any of the following transactions or events with respect to the Company, whether effected
through one transaction or event or through a combination or series of related, arranged, contemplated, or contemporaneous transactions
or events: (A) a sale, exchange, acquisition or other transfer resulting in an acquisition by an individual or legal entity or &ldquo;group&rdquo;
(as described in Rule 13d-5(b)(1) promulgated under the Exchange Act of 1934, as amended) (other than LiveOne or its Affiliates) of effective
control (whether through legal or beneficial ownership of capital stock of the Company, by contract or otherwise) of in excess of 50%
of the voting securities of the Company, (B) (i) the Company merges into or consolidates with any other person (other than LiveOne or
its Affiliates) or any person merges (other than LiveOne or its Affiliates) into or consolidates with the Company, after giving effect
to such transaction, and/or (ii) the Company enters into other transaction or relationship which results in, in either case the stockholders
of the Company (other than LiveOne or its Affiliates) immediately prior to such transaction owning less than 50% of the aggregate voting
power of the Company or the successor entity of such transaction, (c) the issuance of securities of the Company to an individual or legal
entity or &ldquo;group&rdquo; (other than to LiveOne or its Affiliates), which issuance represents in excess of 50% of the voting securities
of the Company after giving effect to such issuance, (d) the Company sells, transfers, licenses, leases or otherwise disposes or conveys
(including any sale and leaseback transaction or by way of a merger) of all or substantially all of its assets to another person (other
than to LiveOne or its Affiliates), or (f) any other transaction, event, arrangement, or relationship having a similar effect on control
of the Company as delineated in this definition. &ldquo;Going Public Transaction&rdquo; means the earlier of (i) the date on which the
Company consummated its direct listing of Company Common Stock on a national stock exchange and (ii) the date of completion of any other
transaction by the Company as a result of which the Company Common Stock is listed on a national stock exchange. By signing this Agreement,
Executive acknowledges that the Company&rsquo;s Insider Trading Policy is, or if adopted after the date hereof shall be, substantially
the same as LiveOne&rsquo;s Insider Trading Policy and further acknowledges receipt and agrees to the terms of such Insider Trading Policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) Subject to approval by
LiveOne&rsquo;s board of directors (&ldquo;LiveOne Board&rdquo;), the Company shall promptly, but no later than thirty (30) days following
the date of this Agreement, cause LiveOne to grant to Executive, as soon as practicable following the Effective Date, but no later than
the first anniversary of the Effective Date, an initial equity grant (the &ldquo;LVO Equity Grant&rdquo;) of seventy five thousand (75,000)
restricted stock units of LiveOne (the &ldquo;LVO RSUs&rdquo; and collectively with the PC1 RSUs, the &ldquo;RSUs&rdquo;). The LVO Equity
Grant shall be made under LiveOne&rsquo;s 2016 Equity Incentive Plan (as amended, modified or restated from time to time, the &ldquo;2016
LVO EIP&rdquo;), and will be evidenced by LiveOne&rsquo;s standard form of Award Agreement (as defined in the 2016 LVO EIP) between Executive
and LiveOne (the &ldquo;LVO Award Agreement&rdquo;). Subject to Section 6, the LVO RSUs shall vest as follows: (i) 50% of the LVO RSUs
shall vest on the Initial Vesting Date, and (ii) the remaining 50% of the LVO RSUs shall vest on the Subsequent Vesting Date, provided
that for each LVO RSUs vesting tranche, Executive is continuously employed by and is in good standing with the Company and this Agreement
is in effect, in each case through each applicable Vesting Date (except as otherwise provided in Section 6). Notwithstanding the foregoing
or anything herein to the contrary, if Executive remains employed through the date of a LVO Change of Control (as defined below), 50%
of Executive&rsquo;s then-unvested LVO RSUs shall vest in full effective immediately prior to such LVO Change of Control. Each respective
vested LVO RSU shall be settled by delivery to Executive of one share of LiveOne&rsquo;s common stock, $0.001 par value per share (the
&ldquo;LVO Common Stock&rdquo;), per vested LVO RSU promptly after the applicable vesting date (each such applicable date, the &ldquo;LVO
Settlement Date&rdquo;). Upon and after each LVO Settlement Date, LiveOne may in its sole discretion (but shall have no obligations whatsoever
to do so), and to the extent permissible under applicable law and LiveOne&rsquo;s Insider Trading Policy, allow Executive to satisfy her
tax obligations arising in connection with the settlement of her vested LVO RSUs through the sale by him in the open market of a number
of shares of LVO Common Stock underlying the vested and settled LVO RSUs up to the maximum amount that would be sufficient to pay the
amount of those tax obligations. &ldquo;LVO Change of Control&rdquo; shall have the meaning of &ldquo;Change of Control&rdquo; provided
in the 2016 LVO EIP, except that (i) for purposes of determining whether a LVO Change of Control has occurred under this Agreement, the
acquisition of additional shares of LVO Common Stock and/or convertible or voting securities by Robert Ellin and/or his Affiliates (as
defined below) resulting in him and/or his Affiliates having Beneficial Ownership (as such term is defined in the Exchange Act) of more
(or less) than 50% of the total voting power of the stock of LiveOne will not be considered a LVO Change of Control, and (ii) for purposes
of the LVO RSUs (and any other amounts payable on a LVO Change of Control that constitute &ldquo;nonqualified deferred compensation&rdquo;
within the meaning of Section 409A), a LVO Change of Control shall only be deemed to occur if such transaction also constitutes a &ldquo;change
of control event&rdquo; within the meaning of Section 409A. By signing this Agreement, Executive acknowledges receipt and agrees to the
terms of LiveOne&rsquo;s Insider Trading Policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)  <U>Tax
Withholding</U>. Company may withhold from any amounts payable hereunder, including any amounts payable pursuant to this Section 3, any
applicable federal, state, and local taxes that the Company is required to withhold pursuant to any applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Benefits</U>:
Executive shall be eligible for those benefits which are made available to other Executive Officers, pursuant to standard Company policies,
including participation in the Company&rsquo;s medical insurance plan (the &ldquo;Benefits&rdquo;). Employee will be entitled to 20 days
of vacation per year, the dates of such vacation must be approved by Company&rsquo;s President or such other person to whom Executive
reports pursuant to Section 1, with no rollover. Company shall promptly pay or reimburse Executive for all reasonable out-of-pocket business
expenses (including without limitation comfort plus travel and accommodation costs) incurred or paid by Executive during the Term directly
in connection with Executive&rsquo;s performance of her duties under this Agreement on a basis appropriate to Executive&rsquo;s position,
upon presentation of reasonably detailed expense statements or vouchers and such other information as the Company may reasonably require
and in accordance with the generally applicable policies and procedures of the Company, and in no event less favorable than that provided
by the Company to any of its Executive Officers, all in accordance with the applicable policies and procedures of the Company. Business
expenses incurred and not submitted for reimbursement within 60 days will not be reimbursable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <U>Services</U>:
During the Term, Executive shall devote all of Executive&rsquo;s working time, business attention, and business efforts to Company, excluding
any periods for illness, incapacity, and vacations, subject to the policies established by the Compensation Committee of the Board as
disclosed to Executive, except as otherwise specifically provided herein. Notwithstanding the immediately preceding sentence or anything
to the contrary contained herein, during the Term Executive is permitted (a) to serve on the boards of directors, the boards of trustees,
or any similar governing bodies, of any corporations or other business entities, of any charitable, educational, religious, or public
service organizations, or of any trade associations, (b) to engage in charitable activities and community affairs, (c) to engage in venture
investing, and (d) to manage Executive&rsquo;s personal investments, in each case so long as such investments do not compete with the
business of Company (except that Executive may be a holder of one percent (1%) or less of the outstanding capital stock of a competing
corporation whose shares are publicly traded on a national securities exchange or through a national market system or registered pursuant
to Section 12(g) of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;)) and do not interfere with Executive&rsquo;s
performance of this Agreement and which shall take first priority over all other such activities as determined in the reasonable discretion
of the Board. Executive will competently perform as an employee in accordance with the duties and responsibilities assigned to Executive
and the Executive will devote her full business time and energies to advance the business and welfare of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. <U>Termination</U>:
(a) This Agreement may be terminated by mutual agreement of the parties or by Company under the following circumstances: (x) death or
Disability (as defined below) of Executive, effective immediately upon such event, or (y) for &ldquo;Cause.&rdquo; For the purposes hereof,
&ldquo;Cause&rdquo; means: (i) Executive&rsquo;s conviction of a felony requiring intent under the laws of the United States or any State
thereof, after the exhaustion of all possible appeals, or Executive entering a plea of nolo contendere to any charge of a felony requiring
intent under the laws of the United States or any State thereof, in each case excluding any Limited Vicarious Liability (as hereinafter
defined); (ii) a willful and substantial refusal by Executive to perform Executive&rsquo;s material duties or responsibilities assigned
to Executive in accordance with the terms of this Agreement, but only if such duties or responsibilities so assigned to Executive are
not inconsistent with (1) Executive&rsquo;s position as CRO of the Company, or (2) any of Executive&rsquo;s duties or responsibilities
hereunder (including any such duties or responsibilities as set forth in, or as contemplated by, Section 1), and, in each case, excluding
any such failure by reason of death, Disability, or incapacity; (iii) any material and willful violation of any written policy of the
Company or LiveOne that is generally applicable to all employees or officers of the Company or LiveOne and that results or which could
be reasonably expected to result in a material negative effect on the business, financial condition or business reputation of the Company
or LiveOne, as determined by the Company in good faith in its reasonable sole discretion; (iv) Executive&rsquo;s willful malfeasance in
the performance of her duties hereunder that has a material negative effect on the business, financial condition or business reputation
of the Company or LiveOne, as determined by the Company in its reasonable sole discretion; (v) Executive failing to comply with the first
sentence of Section 9(a); or any other material breach of this Agreement or the Confidentiality Agreement by Executive, subject Executive&rsquo;s
ability to cure such breach (if capable of being cured) within twenty (20) calendar days following receipt of a written notice from the
Company (email shall suffice); or (vi) Executive engaging in intentional acts of fraud, embezzlement, misappropriation of funds, misconduct,
gross negligence, dishonesty (including, without limitation, theft), violence, threat of violence, sexual misconduct, unlawful or against
the Company&rsquo;s or LiveOne&rsquo;s policies, harassment or any other activity that has resulted or could be reasonably expected to
result in any material negative effect on the business or financial condition or reputation of the Company or LiveOne, as determined by
the Company in good faith in its reasonable sole discretion. For the purposes hereof, the term &ldquo;Disability&rdquo; means Executive&rsquo;s
inability to perform her duties with Company on a full-time basis, even with reasonable accommodation, for thirty (30) business days during
any period of twelve (12) consecutive months, or fifteen (15) consecutive business days, in each case solely as a result of incapacity
due to mental or physical illness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) If Executive&rsquo;s
employment is terminated by the Company for Cause or by Executive for any reason other than Good Reason, then Executive is entitled to
receive or otherwise to be provided, and Company shall pay or provide to Executive: (i) the Accrued Obligations, payable in accordance
with Company&rsquo;s payroll policies, (ii) the timely payment or timely provision of the Benefits in accordance with the terms and conditions
of the applicable benefit plan through and inclusive of effective termination date. All unvested equity or equity awards awarded, granted
or issued pursuant to this Agreement or otherwise by Company or LiveOne and/or their respective affiliates shall be forfeited effective
as of the effective termination date. &ldquo;Accrued Obligations&rdquo; means the aggregate of: (a) Executive&rsquo;s accrued Base Salary
through and inclusive of effective termination date (disregarding any reduction thereto in violation of this Agreement); (b) Executive&rsquo;s
accrued vacation pay through and inclusive of effective termination date; and (c) Executive&rsquo;s business expenses incurred through
and inclusive of effective termination date that have not been reimbursed by Company as of effective termination date. Except as provided
above, this provision shall not apply to forfeit any vested equity or vested shares of Company or LiveOne transferred to or held by or
otherwise owned by Executive prior to the Effective Date.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)  For
the purposes hereof: (i) any act or omission (including any refusal or violation) by Executive is &ldquo;willful&rdquo; only if the same
is not in good faith and is without the reasonable belief by Executive that such act or omission is in the best interests of the Company;
and (ii) any act or omission by Executive based upon any authority granted pursuant to a resolution duly adopted by the Board or based
upon the advice of counsel for the Company in each case is presumed to be in good faith and in the best interests of the Company. For
the purposes hereof, &ldquo;Limited Vicarious Liability&rdquo; means any liability that (1) is based on acts or omissions of the Company
for which Executive is responsible solely as a result of her responsibilities with the Company, where Executive was not directly involved
in such acts or omissions and either had no prior knowledge of such intended acts or omissions or upon obtaining any such knowledge promptly
acted reasonably and in good faith to attempt to prevent the acts or omissions causing such liability, or (2) Executive did not have a
reasonable basis to believe that any applicable law was being violated by such acts or omissions. With respect to Section 6(a)(ii), (iii)
and (iv), &ldquo;Cause&rdquo; shall not exist unless Executive fails to cure such act or omission (if capable of being cured) on or before
the date twenty (20) calendar days after the date on which Executive receives such notice from the Company (email shall suffice), which
shall be provided by Company on or before the date that is sixty (60) calendar days after the date on which Company becomes aware of the
act or omission constituting Cause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)  Executive
may terminate her employment with Company for Good Reason (as defined below) only by providing a written termination notice to Company
on or before the date thirty (30) calendar days after the date on which Executive becomes aware of the act or omission constituting Good
Reason, which shall take effect only if Company shall not cure such basis for Good Reason (if capable of being cured) within twenty (20)
calendar days following receipt of such termination notice (email shall suffice) and, unless otherwise agreed to by the parties, termination
shall be effective upon the expiration of such cure period, if applicable. For the purposes hereof, &ldquo;Good Reason&rdquo; means, without
Executive&rsquo;s written prior written consent (email shall suffice): (i) any material reduction in Executive&rsquo;s then-current Base
Salary (unless the other senior executives of Company are subject to the same reduction); or (ii) any material breach of this Agreement
by Company (subject to the cure period as provided herein). For purposes of this Section 6(d), materiality shall be defined as a reduction
of Executive&rsquo;s then-current Base Salary of 10% of more, or any material breach of this Agreement by Company, which is not cured
during the cure period as provided herein. If Executive&rsquo;s employment is terminated by Executive for Good Reason or by the Company
without Cause (other than as a result of the expiration of this Agreement or death or Disability of Executive), then Executive is entitled
to receive or otherwise to be provided, and Company shall pay or provide to Executive: (x) the GR Accrued Obligations, payable in accordance
with Company&rsquo;s payroll policies, and (y) the timely payment or timely provision of the Benefits in accordance with the terms and
conditions of the applicable benefit plan through the effective termination date. &ldquo;GR Accrued Obligations&rdquo; means the aggregate
of: (a) Executive&rsquo;s accrued then effective Base Salary through and inclusive of the date that is the lesser of (x) 6 months from
the effective termination date (disregarding any reduction thereto in violation of this Agreement) and (y) the remaining period of the
Term; (b) Executive&rsquo;s accrued vacation pay through and inclusive of effective termination date; (c) 100% vesting of any unvested
RSUs and (d) except as provided herein, Executive&rsquo;s business expenses incurred in connection with the Company&rsquo;s business in
accordance with the Company&rsquo;s policies and through and inclusive of effective termination date that have not been reimbursed by
Company as of effective termination date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) In
connection with any termination of Executive&rsquo;s employment by Company without Cause or Executive for Good Reason, and as a condition
of any payment by Company or acceleration of vesting of any unvested RSUs or other unvested equity as required by Section 6, each of Company
and Executive shall execute and deliver to each other a mutual general release in Company&rsquo;s standard and customary form and substance
(including, without limitation, a full release of LiveOne and its Affiliates), and Executive&rsquo;s right to payment of, and the Company&rsquo;s
obligations to pay, any obligations provided herein shall be subject to Executive&rsquo;s execution (without revocation) of such release
within the provided period or otherwise and her continued compliance with the terms of such mutual general release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)  If
this Agreement is not terminated before the last day of the Term and prior to that date Company and Executive do not (i) enter into a
mutually acceptable extension of this Agreement, or (ii) enter into a new agreement relating to Executive&rsquo;s employment with Company
to have effect after such date, or (iii) otherwise agree to continue Executive&rsquo;s employment with Company after such date without
the benefit of an agreement relating to such employment, then this Agreement shall automatically end on the last day of the Term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)  The
termination of Executive&rsquo;s employment with Company for any reason will constitute Executive&rsquo;s immediate resignation from (a)
any officer, director or employee position Executive has with Company, LiveOne or any of their respective affiliates, and (b) all fiduciary
positions (including as a trustee) Executive holds with respect to any employee benefit plans or trusts established by Company or LiveOne.
Executive agrees that this Agreement shall serve as written notice of resignation in such circumstances, unless otherwise required by
any plan or applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7. <U>No
Waiver/Severability</U>: The waiver of a breach of any term or condition of this Agreement shall not be deemed to constitute the waiver
of any further breach of such term or condition or the waiver of any other term or condition of this Agreement. Nothing contained in this
Agreement shall be construed as prohibiting Company or LiveOne from pursuing any other remedies available to it for any breach or threatened
breach, including the recovery of money damages. If any provision of this Agreement is determined to be illegal, invalid, or unenforceable,
then such determination does not affect the legality, validity, or enforceability of the other provisions of this Agreement, all of which
remain in full force and effect. Each of Company and Executive agrees that in the event of any such determination Company and Executive
will negotiate to modify this Agreement so as to effect the original intent of Company and Executive as close as possible to the fullest
extent permitted by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8. <U>Notice</U>.
Each notice or other communication relating to this Agreement, in order to be effective, must be in writing, must be sent to the applicable
address indicated below for the recipient (or to the then-most recent address of which the recipient has notified the sender in writing
in accordance herewith), and must be sent, all costs, expenses, and fees prepaid by the sender, by (a) personal delivery, (b) first class
registered mail, return receipt requested, (c) a nationally recognized courier service that provides proof of delivery (e.g., FedEx, UPS)
for delivery on the first business day immediately following the day on which the notice or other communication is deposited with the
courier service, or (d) via email. Each notice or communication given in accordance herewith is deemed effective: (i) upon actual receipt
when delivered personally or by courier service, (ii) three (3) business days after the date on which the notice or communication is deposited
with the United States Postal Service, if sent by first class registered mail (or any earlier date evidenced by the proof of delivery),
or (iii) if being sent by email, upon confirmation of receipt. If to Company: to the attention of Company&rsquo;s Executive Chairman and
CEO, at the address of Company&rsquo;s principal place of business, with a copy to (which shall not constitute notice) Sasha Ablovatskiy,
Esq., Foley Shechter Ablovatskiy LLP, 1180 Avenue of the Americas, 8th Floor, New York, New York 10036. If to Executive: to the address
listed as Executive&rsquo;s primary residence in the human resource records and to Executive&rsquo;s principal place of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.  <U>Miscellaneous</U>.
(a) This Agreement is personal to Executive and Executive may not assign or delegate this Agreement or her obligations hereunder without
the prior written consent of Company. The Company may not assign or delegate this Agreement or its obligations hereunder without the prior
written consent of Executive, except that the Company may assign or delegate this Agreement to any successor (whether direct or indirect,
whether by purchase, merger, consolidation, operation of law, PC1 Change of Control, LVO Change of Control or otherwise) to all or substantially
all of the business or assets of the Company and/or LiveOne, subject to the condition that the successor, no later than fifteen (15) days
after the occurrence of such succession, executes and delivers to Executive an instrument in from and substance acceptable to Executive
(such approval not to be unreasonably withheld, conditioned or delayed) pursuant to which the successor explicitly assumes and agrees
to perform, comply with, and otherwise be bound by this Agreement in the same manner and to the same extent that the Company would be
required to do so if no such succession had occurred. Subject to the immediately preceding sentence, this Agreement is binding upon and
inures to the benefit of the Company and LiveOne and its permitted successors and permitted assigns. As used in this Agreement, the term
&ldquo;Company&rdquo; means the Company as hereinbefore defined and any successor to is business or assets as aforesaid that assumes and
agrees to perform this Agreement, whether by operation of law or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) This
Agreement shall be governed by the laws of the State of California applicable to agreements made and performed wholly therein (excluding
any conflict of laws principles of that State that would result in the application of the laws of any jurisdiction other than State of
California) govern all matters in connection with, relating to, or arising from this Agreement. Any action or proceeding seeking to enforce
any provision of, or based on any right arising out of, this Agreement may be brought against a party hereto in any state or federal courts
located in the City of Los Angeles, State of California, and each party consents to the jurisdiction of such courts (and of the appropriate
appellate courts) in any such action or proceeding and waives any objection to venue laid therein. Process in any action or proceeding
referred to in the preceding sentence may be served on any party anywhere in the world. Executive acknowledges and agrees that Company
has made no representations or offers other than those set forth herein. This Agreement is the final expression of the agreement between
the Company and Executive. This Agreement may be amended at any time, but only by written instrument signed by the parties hereto. The
Confidentiality Agreement executed by the Executive shall be considered as addendum(s) hereto. This Agreement inures to the benefit of
and is enforceable by Executive&rsquo;s legal representatives, heirs, or legatees. The following provisions survive the expiration or
termination of the Term: (including any termination by reason of Executive&rsquo;s breach of this Agreement): <U>Section 3(d)</U> (Tax
Withholding), <U>Section 6</U> (Termination), and Sections 7 through 9 (inclusive). The Confidentiality Agreement shall survive the expiration
or termination of the Employment Period and the Term on the terms thereof. Each party shall pay the fees and expenses of her or its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of this Agreement. This Agreement may be executed in multiple counterparts, each of which constitutes
an original and all of which together constitute one and the same instrument. A manually executed counterpart of this Agreement delivered
by means of e-mail as a Portable Document Format file (&ldquo;.pdf&rdquo;) (or in any present or future file format intended to preserve
the original graphic and pictorial appearance of a document), or by means of electronic or facsimile transmission, constitutes the valid
and effective execution and delivery of this Agreement for all purposes and has the same force and effect for all purposes as the personal
delivery of a manually executed counterpart bearing an original ink signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>Signature page follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By signing below, each of
Company and Executive acknowledges that it or she has carefully read, fully understands, and accepts and agrees to be bound by the provisions
of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"><B></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COURTSIDE GROUP, INC.</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Kit Gray</I></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kit Gray</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Executive:</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Sue McNamara</I></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sue McNamara</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><U>CONFIDENTIALITY, NON-INTERFERENCE
AND INVENTION ASSIGNMENT AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">As a condition of my becoming
employed by, or continuing employment with, Courtside Group, Inc., a Delaware Corporation (the &ldquo;<B>Company</B>&rdquo;), and in consideration
of my employment with the Company and my receipt of the compensation now and hereafter paid to me by the Company, I agree to the following.
All initially capitalized terms used but not defined herein have the respective meanings given to such terms in the employment offer letter
between the Company and me dated as of August 9, 2023 (as amended, modified or restated, the &ldquo;<B>Employment Agreement</B>&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">1. <B><U>Confidential
Information</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">1.1 <U>Company
Group Information</U>. I acknowledge that, during the course of my employment, I will have access to non-public information about the
Company, LiveOne and their respective direct and indirect subsidiaries and affiliates (collectively, the &ldquo;<B>Company Group</B>&rdquo;)
and that my employment with the Company shall bring me into close contact with confidential and proprietary information of the Company
Group. In recognition of the foregoing, I agree, at all times during the term of my employment with the Company and for the five (5) year
period following my termination of my employment for any reason, to hold in confidence, and not to use, except for the benefit of the
Company Group, or to disclose to any person, firm, corporation, or other entity without written authorization of the Company or except
as expressly permitted herein, any Confidential Information that I obtain or create. This Agreement is made to the extent that one or
more obligations do not conflict with California Business and Professions Code &sect; 16600, et seq. (&ldquo;Section 16600&rdquo;). If
a court with appropriate jurisdiction over the parties hereto determines by a final non-appealable decision, that one or more obligations
of this Agreement conflicts with Section 16600 or other applicable statutory or common law, Section 16600 or other applicable law shall
prevail solely with respect to such provision of this Agreement that directly conflicts with Section 16600 or other applicable law, and
Section 16600 or other applicable law shall apply solely with respect to such conflicting provision. Notwithstanding the foregoing, Section
6(e) of the Employment Agreement shall continue to apply as a condition of any payment required by such Section 6(e). I further agree
not to make copies of such Confidential Information except as authorized by the Company, or except as permitted herein, or as otherwise
necessary to fulfill my duties to the Company. For the purposes hereof, &ldquo;<B>Confidential Information</B>&rdquo; means information
that the Company Group has developed, acquired, created, compiled, discovered, or owned or will develop, acquire, create, compile, discover,
or own, that has value in or to the business of the Company Group that is not generally known and that the Company wishes to maintain
as confidential. I understand that Confidential Information includes, but is not limited to, any and all non-public information that relates
to the actual or anticipated business and/or products, research, or development of the Company, or to the Company&rsquo;s technical data,
trade secrets, or know-how, including, without limitation, proposals and development work for television programs, formats, copyright
works, research, product plans, or other information regarding the Company&rsquo;s products or services and markets, customer lists, and
customers (including, without limitation, customers of the Company on whom I called or with whom I may become acquainted during the term
of my employment), software, developments, inventions, processes, formulas, technology, designs, drawings, engineering, hardware configuration
information, marketing, finances, and other business information disclosed by the Company either directly or indirectly in writing, orally,
or by drawings or inspection of premises, parts, equipment, or other Company property. Notwithstanding the foregoing: (a) Confidential
Information shall not include (i) any of the foregoing items that are, or become, publicly known through no unauthorized disclosure by
me, (ii) any of the foregoing items lawfully disclosed to me free of restriction from a source that was not legally or contractually prohibited
from disclosing such item, or (iii) any of the foregoing items or other information that I had or owned prior to my employment with the
Company; and (b) I am entitled to disclose Confidential Information (i) as agreed to in writing by the Company (other than as authorized
in my capacity as an officer of the Company), (ii) within the Company Group to the extent necessary to perform my duties under this Confidentiality,
Non-Interference and Invention Assignment (this &ldquo;<B>Agreement</B>&rdquo; or this &ldquo;<B>Confidentiality Agreement</B>&rdquo;),
(iii) to my attorneys and accountants on a need-to-know basis in connection with asserting my rights under the Employment Agreement or
this Agreement (provided such attorneys and accountants agree in writing to not otherwise disclose such Confidential Information, (iv)
if reasonably necessary to defend my interests, or (v) to make any claim, pursuant to a litigation, arbitration or mediation involving
this Agreement, provided, that with respect to clauses (iv) and (v) in any such defense, litigation, arbitration, mediation or any other
proceeding, the parties agree to enter into a reasonable confidentiality order or agreement to preserve the confidentiality of any such
Confidential Information used in such defense, litigation, arbitration, mediation or any other proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.8in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.8in"></P>

<!-- Field: Page; Sequence: 9; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.8in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">1.2 Notwithstanding
anything to the contrary contained herein, I am permitted to disclose any Confidential Information if and to the extent I am required
to do so by applicable law, including without limitation by, or pursuant to any order of, any court, tribunal, or other governmental,
judicial, arbitral, administrative, or regulatory authority, agency, or instrumentality. In the event I am so required to disclose any
Confidential Information, I will, if permitted pursuant to applicable law, inform such requesting party of the confidentiality obligations
hereunder and give the Company prompt prior notice thereof so that the Company Group, at its sole cost and expense, may seek an appropriate
protective order and/or waive compliance with the confidentiality provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.8in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">1.3 <U>Former
Employer Information</U>. I represent that my performance of all of the terms of this Confidentiality Agreement as an employee of the
Company has not breached and will not breach any agreement to keep in confidence proprietary information, knowledge, or data acquired
by me in confidence or trust prior or subsequent to the commencement of my employment with the Company, and I will not disclose to any
member of the Company Group, or induce any member of the Company Group to use, any developments, or confidential or proprietary information
or material I may have obtained in connection with employment with any prior employer in violation of a confidentiality agreement, nondisclosure
agreement, or similar agreement with such prior employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.8in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">2. <B><U>Developments</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">2.1 <U>Developments
Retained and Licensed</U>. I hereby represent and warrant that there are not any developments, original works of authorship, improvements,
or trade secrets which were created or owned by me prior to the commencement of the Employment Period (collectively referred to as &ldquo;<B>Prior
Developments</B>&rdquo;). If the foregoing representation and warranty is breached, and during any period during which I perform or performed
services for the Company both before or after the date hereof (the &ldquo;<B>Assignment Period</B>&rdquo;), I incorporate or have incorporated
into a Company product, program, service or other work a Prior Development owned by me or in which I have an interest, then I hereby grant
the Company a non-exclusive, royalty-free, irrevocable, perpetual, worldwide license (with the right to sublicense) to make, have made,
copy, modify, make derivative works of, use, sell and otherwise distribute such Prior Development, to the extent of my interest therein,
as part of or in connection with such product, program, service or work.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.8in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">2.2 <U>Assignment
of Developments</U>. I hereby assign to the Company all my right, title and interest throughout the world (if any) in and to any and all
(i) inventions (whether patentable or unpatentable and whether or not reduced to practice), all improvements thereto, and all patents,
patent applications, and patent disclosures, together with all reissuances, continuations, continuations-in-part, revisions, extensions
and reexaminations thereof, (ii) trademarks, service marks, trade dress, logos, titles and working titles, together with all translations,
adaptations, derivations, and combinations thereof and including all goodwill associated therewith, and all applications, registrations
and renewals in connection therewith, (iii) copyrightable works, all copyrights, and all applications, registrations and renewals in connection
therewith, (iv) trade secrets and confidential business information (excluding general industry knowledge and contacts) and all ideas,
research and development, know-how, formulas, compositions, manufacturing and production processes and techniques, technical data, designs,
drawings, specifications, technology, systems, and business and marketing plans and proposals, (v) rights in and to computer software
(including object code, source code, data and related documentation), (vi) Internet Web sites, including domain name registrations and
content and software included therein, (vii) other proprietary rights, including, without limitation, original works of authorship, content,
dialogue, plots, scripts, scenarios, music programming, formats, graphics, productions, products, programs, services, concepts, moral
rights, rights to characters, actions, acts, gags, routines, materials, ideas, names, likeness, image, personality, publicity etc., (viii)
rights to exploit, collect remuneration for, and recover for past infringements of any of the foregoing and (ix) copies and tangible embodiments
thereof (in whatever form or medium), whether or not patentable or registrable under copyright or similar laws, which I may solely or
jointly conceive or develop or reduce to practice or cause to be conceived or developed or reduced to practice, or have conceived or developed
or reduced to practice or have caused to be conceived or developed or reduced to practice, during the Employment Period, whether or not
during regular working hours, in each case only if the applicable item (A) relates at the time of conception or development to the actual
or demonstrably proposed business or research and development activities of the Company; (B) results from or relates to any work performed
by me for the Company or any of its Affiliates; and (C) is developed through the use of Confidential Information and/or resources of the
Company (collectively referred to as &ldquo;<B>Developments</B>&rdquo;). I further acknowledge that all Developments which are or were
made by me (solely or jointly with others) during the Assignment Period are &ldquo;works made for hire&rdquo; as to my contribution (to
the greatest extent permitted by applicable law) for which I am, in part, compensated by my salary, unless regulated otherwise by law,
but that, in the event any such Development is deemed not to be a work made for hire, I hereby assign any right, title and interest throughout
the world in any such Development to the Company or its designee. If any Developments cannot be assigned, I hereby grant to the Company
an exclusive, assignable, irrevocable, perpetual, worldwide, sublicensable (through one or multiple tiers), royalty-free, unlimited license
to use, make, modify, sell, offer for sale, reproduce, distribute, create derivative works of, publicly perform, publicly display and
digitally perform and display such work in any media now known or hereafter known. Outside the scope of my service, whether during or
after my employment with the Company, I agree not to (x) modify, adapt, alter, translate, or create derivative works from any such work
of authorship or (y) merge any such work of authorship with other Developments. To the extent rights related to paternity, integrity,
disclosure and withdrawal (collectively, &ldquo;<B>Moral Rights</B>&rdquo;) may not be assignable under applicable law and to the extent
the following is allowed by the laws in the various countries where Moral Rights exist, I hereby irrevocably waive such Moral Rights in
and to all or any Developments and consent to any action of the Company Group that would violate such Moral Rights in the absence of such
consent. I understand that the provisions of this Confidentiality Agreement requiring assignment of Inventions to the Company do not apply
to any invention which qualifies fully under the provisions of Section 2870 of the California Labor Code (attached hereto as Schedule
A). I will advise the Company promptly in writing of any inventions that I believe meet the criteria in Section 2870 of the California
Labor Code and I bear the full burden of proving to the Company Group that an invention qualifies fully under Section 2870 of the California
Labor Code. I acknowledge receipt of this Confidentiality Agreement and of written notification of the provisions of Section 2870 of the
California Labor Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.8in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.8in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.8in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">2.3 <U>Maintenance
of Records</U>. I agree to keep and maintain adequate and current written records of all Developments made by me (solely or jointly with
others) during the Assignment Period. The records may be in the form of notes, sketches, drawings, flow charts, electronic data or recordings,
and any other format. The records will be available to and remain the sole property of the Company at all times. I agree not to remove
such records from the Company&rsquo;s place of business except as expressly permitted by Company policy, which may, from time to time,
be revised at the sole election of the Company for the purpose of furthering the business of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.8in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">2.4 <U>Intellectual
Property Rights</U>. I agree to reasonably assist the Company, or its designee, at the Company&rsquo;s expense, in every way to secure
the rights of the Company in the Developments and any copyrights, patents, trademarks, service marks, database rights, domain names, mask
work rights, moral rights, or other intellectual property rights relating thereto in any and all countries, including the disclosure to
the Company of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments,
recordations, and all other instruments which the Company shall deem reasonably necessary in order to apply for, obtain, maintain and
transfer such rights and in order to assign and convey to the Company the sole and exclusive right, title and interest in and to such
Developments, and any intellectual property or other proprietary rights relating thereto. I further agree that my obligation to execute
or cause to be executed, when it is in my power to do so, any such instrument or papers shall continue after the Assignment Period until
the expiration of the last such intellectual property right to expire in any country of the world; provided, however, the Company shall
reimburse me for my reasonable expenses incurred in connection with carrying out the foregoing obligation. If the Company is unable because
of my mental or physical incapacity or unavailability for any other reason to secure my signature to apply for or to pursue any application
for any United States or foreign patents or copyright registrations covering Developments or original works of authorship assigned to
the Company as above, then I hereby irrevocably designate and appoint the Company and its duly authorized officers and agents as my agent
and attorney in fact, to act for and in my behalf and stead only to execute and file any such applications or records and only to do all
other lawfully permitted acts to further the application for, prosecution, issuance, maintenance or transfer of letters patent or registrations
thereon with the same legal force and effect as if originally executed by me. I hereby waive and irrevocably quitclaim to the Company
any and all claims, of any nature whatsoever, which I now or hereafter have for past, present or future infringement of any and all proprietary
rights assigned to the Company hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.8in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">3. <B><U>Returning
Company Group Documents</U>.</B> I agree that, at the time of termination of my employment with the Company for any reason, or earlier
if reasonably requested, I will deliver to the Company (and will not keep in my possession, recreate, or deliver to anyone else) any and
all Confidential Information and all other documents, materials, information, and property developed by me pursuant to my employment or
otherwise belonging to the Company. I agree further that any property situated on the Company&rsquo;s premises and owned by the Company
(or any other member of the Company Group), including disks and other storage media, filing cabinets, and other work areas, is subject
to inspection by personnel of any member of the Company Group at any time with or without notice. Notwithstanding the foregoing, I will
be permitted to retain my rolodex (whether in written or electronic form (e.g. Microsoft Outlook Contacts)) and my personal files and
memorabilia, except to the extent any of such contains Confidential Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">4. <B><U>Disclosure
of Agreement</U>.</B> As long as it remains in effect and during the Post-Termination Non-Interference Period, I will disclose the existence
of this Confidentiality Agreement and my obligations hereunder to any prospective employer, partner, co-venturer, investor, or lender
prior to entering into an employment, partnership, or other business relationship with such person or entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5. <B><U>Restrictions
on Interfering</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">5.1 <U>Non-Interference</U>.
During the period of my employment with the Company (the &ldquo;<B>Employment Period</B>&rdquo;) and the Post-Termination Non-Interference
Period, I shall not, directly or indirectly for my own account or for the account of any other individual or entity, engage in Interfering
Activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.8in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.8in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.8in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">5.2 <U>Definitions</U>.
For purposes of this Confidentiality Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.8in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(a) &ldquo;<B>Business
Relation</B>&rdquo; shall mean any current or prospective client, customer, licensee, account, supplier or other business relation of
the Company Group, or any such relation that was a client, customer, licensee, account, supplier, or other business relation within the
six (6) month period prior to the expiration of the Employment Period, in each case, to whom I provided services, or with whom I transacted
business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(b) &ldquo;<B>Interfering
Activities</B>&rdquo; means (A) encouraging, soliciting, or inducing, or in any manner attempting to encourage, solicit, or induce, any
Person employed by, or providing consulting, podcasting or any other services to, any member of the Company Group (each, a &ldquo;<B>Restricted
Associate</B>&rdquo;) to terminate such Person&rsquo;s employment or services (or in the case of a consultant, materially reducing such
services) with the Company Group, provided that the foregoing shall not be violated by general advertising not targeted at employees or
consultants of any member of the Company Group; or (B) encouraging, soliciting, or inducing, or in any manner attempting to encourage,
solicit, or induce, any Business Relation to cease doing business with or reduce the amount of business conducted with the Company Group,
or in any way interfering with the relationship between any such Business Relation and the Company Group. Notwithstanding the foregoing,
for the purposes hereof the term &ldquo;Interfering Activities&rdquo; excludes my taking all or any of the following actions, whether
for my account or benefit or for the account or benefit of any other Person: (x) hiring any Restricted Associate or engaging any Restricted
Associate to otherwise render services (whether consulting or otherwise), so long as in connection therewith I do not knowingly encourage,
induce, or solicit, or knowingly attempt to encourage, induce, or solicit, the respective Restricted Associate in violation of the above
clause (A) of this definition; (y) engaging in, accepting, or otherwise conducting business with any Business Relation, so long as in
connection therewith I do not knowingly encourage, solicit, or induce, or knowingly attempt to encourage, solicit, or induce, the respective
Business Relation in violation of the above clause (B) of this definition; or (z) communicating, or any Person at my direction communicating,
to any Persons, including, without limitation, any Restricted Associate or any Business Relation, by any means, method, media, or format
now or hereafter known (including, without limitation, via any present or future social media service, such as, without limitation, LinkedIn,
Facebook, or Twitter), any change in my employment, including, but not limited to, the cessation of my employment with the Company or
my employment with any Person other than the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(c) &ldquo;<B>Person</B>&rdquo;
means any individual, corporation, partnership, limited liability company, joint venture, association, joint-stock company, trust (charitable
or non-charitable), unincorporated organization, or other form of business entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(d) &ldquo;<B>Post-Termination
Non-Interference Period</B>&rdquo; means the period commencing on the date of the termination of my employment with the Company for any
reason and ending on the twelve (12) month anniversary of such date of termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">6. <B><U>Reasonableness of
Restrictions</U>.</B> I acknowledge and recognize the highly competitive nature of the Company&rsquo;s business, that access to Confidential
Information renders me special and unique within the Company&rsquo;s industry, and that I will have the opportunity to develop substantial
relationships with existing and prospective clients, accounts, customers, consultants, contractors, investors, and strategic partners
of the Company Group during the course of and as a result of my employment with the Company. In light of the foregoing, I recognize and
acknowledge that the restrictions and limitations set forth in this Confidentiality Agreement are reasonable and valid in geographical
and temporal scope and in all other respects and are essential to protect the value of the business and assets of the Company Group.
I acknowledge further that the restrictions and limitations set forth in this Confidentiality Agreement will not materially interfere
with my ability to earn a living following the termination of my employment with the Company and that my ability to earn a livelihood
without violating such restrictions is a material condition to my employment with the Company.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">7. <B><U>Independence;
Severability; Blue Pencil</U>.</B> Each of the rights enumerated in this Confidentiality Agreement shall be independent of the others
and shall be in addition to and not in lieu of any other rights and remedies available to the Company Group at law or in equity. If any
of the provisions of this Confidentiality Agreement or any part of any of them is hereafter construed or adjudicated to be invalid or
unenforceable, the same shall not affect the remainder of this Confidentiality Agreement, which shall be given full effect without regard
to the invalid portions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in"><B></B></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">8. <B><U>Injunctive
Relief</U>.</B> I expressly acknowledge that any breach or threatened breach of any of the terms and/or conditions set forth in this Confidentiality
Agreement may result in substantial, continuing, and irreparable injury to the members of the Company Group. Therefore, I hereby agree
that, in addition to any other remedy that may be available to the Company, any member of the Company Group shall be entitled to seek
injunctive relief, specific performance, or other equitable relief by a court of appropriate jurisdiction in the event of any breach or
threatened breach of the terms of this Confidentiality Agreement without the necessity of posting of a bond.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">9. <B><U>General
Provisions</U>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">9.1 <U>Governing
Law</U>. Except where preempted by federal law, all matters in connection with, relating to, or arising from this Confidentiality Agreement,
including, without limitation, the validity, interpretation, construction, and performance of this Confidentiality Agreement, is governed
by and is to be construed under the laws of the State of California applicable to agreements made and to be performed in that state, without
regard to conflict of laws rules of the State of California that would result in the application of the laws of any jurisdiction other
than the State of California. Any action or proceeding seeking to enforce any provision of, or based on any right arising out of, this
Confidentiality Agreement may be brought against a party hereto in any state or federal courts located in the City of Los Angeles, State
of California, and each party consents to the jurisdiction of such courts (and of the appropriate appellate courts) in any such action
or proceeding and waives any objection to venue laid therein. Process in any action or proceeding referred to in the preceding sentence
may be served on any party anywhere in the world.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.8in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">9.2 <U>Entire
Agreement</U>. This Confidentiality Agreement sets forth the entire agreement and understanding between the Company and me relating to
the subject matter herein and merges all prior discussions and communications between the Company and me relating to the same. No modification
or amendment to this Confidentiality Agreement, nor any waiver of any rights under this Confidentiality Agreement, will be effective unless
in writing and signed and delivered by each of the Company and me. Any subsequent change or changes in my duties, obligations, rights,
or compensation will not affect the validity or scope of this Confidentiality Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.8in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">9.3 <U>Successors
and Assigns</U>. Notwithstanding anything to the contrary contained in the Employment Agreement or in this Confidentiality Agreement,
each party is prohibited from assigning or delegating all or any portion of this Confidentiality Agreement except in compliance with this
<U>Section 9.3</U> in connection with an assignment or delegation of the Employment Agreement that is effected in compliance with <U>Sections
9(a)</U> of the Employment Agreement. Subject to the two immediately preceding sentences, this Confidentiality Agreement will be binding
upon my heirs, executors, administrators, and other legal representatives and will be binding upon and for the benefit of the Company,
its successors, and its assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.8in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">9.4 <U>Survival</U>. The provisions
of this Confidentiality Agreement shall survive the termination of my employment with the Company and/or the assignment, in compliance
with the requirements hereof, of this Confidentiality Agreement by the Company to any successor in interest or other assignee, in each
case subject to the temporal limitations contained herein.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.8in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">9.5 <U>Construction</U>.
Each party hereto has had an adequate opportunity to have this Confidentiality Agreement reviewed by counsel. If an ambiguity or question
of intent or interpretation arises, this Confidentiality Agreement shall be construed as if drafted jointly by the parties hereto. This
Confidentiality Agreement shall be construed without regard to any presumption, rule or burden of proof regarding the favoring or disfavoring
of any party hereto by virtue of the authorship of any of the provisions of this Confidentiality Agreement. In the event any of the provisions
of this Confidentiality Agreement conflict with any of the provisions of the Employment Agreement, the respective provisions of the Employment
Agreement govern and control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.8in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">[SIGNATURE PAGE FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in">I, Sue McNamara, have executed
this Confidentiality, Non-Interference, and Invention Assignment Agreement on the date set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sue McNamara</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Sue McNamara</I></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature)</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: August 9, 2023</FONT></TD>
    </TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACCEPTED AND AGREED TO:</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COURTSIDE GROUP, INC.</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Kit Gray</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kit Gray</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 9, 2023</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 14; Options: NewSection; Value: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Annual Bonus Plan</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">[<I>see attached</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">See Exhibit 10.2 to this Current
Report on Form 8-K</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 15; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Participant Acknowledgment</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Participant acknowledges receipt of a copy
of this Notice and Courtside Group, Inc.&rsquo;s (the &ldquo;<B><I>Company</I></B>&rdquo;) 2023 Annual Bonus Plan (the &ldquo;<B><I>Plan</I></B>&rdquo;),
dated as of August 9, 2023 (and if applicable, the Award Agreement) and represents that he or she is familiar with the provisions hereof
and thereof, and hereby accepts any Awards awarded to the Participant subject to all of the terms and provisions hereof and thereof. The
Participant has reviewed this Notice and the Plan (and if applicable, the Award Agreement) in their entirety, has had an opportunity to
obtain the advice of legal counsel prior to executing this Notice, and fully understands all provisions of this Notice and the Plan (and
if applicable, the Award Agreement). The Participant hereby agrees that all questions of interpretation and administration relating to
this Notice and the Plan (and if applicable, the Award Agreement) shall be solely resolved by the Committee and the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Participant hereby acknowledges that he or
she has had the opportunity to review with his own tax advisors the tax consequences of receiving this Notice and the Plan (and if applicable,
the Award Agreement), and the transactions contemplated thereby, including any U.S. federal, state and local tax laws, and any other applicable
taxing jurisdiction, prior to executing this Notice. Participant attests that he is relying solely on such advisors and not on any statements
or representations of the Company or any of its agents or affiliates. Further, Participant hereby acknowledges and understands that he
(and not the Company) shall be solely responsible for his or her tax liability that may arise as a result of receiving any Award (and
if applicable, the Award Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PARTICIPANT:</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Sue McNamara</I></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature)</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Print Name: Sue McNamara</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: August 9, 2023</FONT></TD>
    </TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">B-2<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ea183613ex10-2_courtside.htm
<DESCRIPTION>THE COMPANY'S 2023 ANNUAL BONUS PLAN
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>COURTSIDE GROUP, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>2023 ANNUAL BONUS PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>I.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PURPOSES
OF THE PLAN</B></FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.01.  The
Courtside Group, Inc. (the &ldquo;<B><I>Company</I></B>&rdquo;) 2023 Annual Bonus Plan<B>&nbsp;</B>(the &ldquo;<B><I>Plan</I></B>&rdquo;),
effective as of August 9, 2023 (the &ldquo;<B><I>Effective Date</I></B>&rdquo;), is hereby established under the Company&rsquo;s 2022
Equity Incentive Plan (the &ldquo;<B><I>EIP</I></B>&rdquo;). The Plan is intended to promote the interests of the Company by creating
an incentive program, which will pay out in cash, stock or both, to (i) attract and retain employees who will strive for excellence and
(ii) motivate those individuals to achieve above-average results by providing them with rewards for contributions to the financial performance
of one or more business segments or business units of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>II.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ADMINISTRATION
OF THE PLAN</B></FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.01. The
Plan is hereby adopted by the Company&rsquo;s Board of Directors (the &ldquo;<B><I>Board</I></B>&rdquo;) to govern &ldquo;<B><I>Awards</I></B>&rdquo;
(sometimes referred to in this Plan as the &ldquo;<B><I>Bonuses</I></B>&rdquo;) under the Plan and shall be administered by the Committee
pursuant to the administrative authority provided to the Committee by the Board, subject to the Board&rsquo;s or its compensation committee&rsquo;s
final approval of any such Awards. The Committee shall have the discretion to determine the portion of the Awards to be paid in cash and
the portion to be paid in the Company&rsquo;s shares of common stock, $0.0001 par value per share (the &ldquo;<B><I>Common Stock</I></B>&rdquo;),
or restricted stock units of the Company (the &ldquo;<B><I>RSUs</I></B>&rdquo;), which shares, if applicable, will be issued under the
EIP, subject to the Board&rsquo;s or its compensation committee&rsquo;s final approval of any such Awards and its cash and stock components
and the value thereof. &ldquo;<B><I>Committee</I></B>&rdquo; shall mean a committee of the following three (3) current executives of the
Company, consisting as of the date of this Plan of Kit Gray, the Company&rsquo;s President, Robert S. Ellin, the Company&rsquo;s Executive
Chairman and a director, and Aaron Sullivan, the Company&rsquo;s Interim Chief Financial Officer. If for any reason any such Committee
member shall be removed or is no longer serving on the Committee, the Board shall appoint a replacement member of the Committee that will
be an executive officer of the Company with direct ties to the Company&rsquo;s operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.02. The
Bonuses that may be earned under the Plan shall be tied to the financial performance of the Company and the price of the Common Stock
for the Company&rsquo;s applicable fiscal year ending March 31, 2024 and 2025 (the &ldquo;<B><I>Fiscal Years&rdquo;</I></B>). The applicable
performance goals for the Company for each Fiscal year are set forth on <B><U>Schedule I</U></B> attached hereto (the &ldquo;<B><I>Performance
Goals Schedule</I></B>&rdquo;), which Performance Goals Schedule shall be subject to approval of the Board in connection with the establishment
of this Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.03. The
interpretation and construction of the Plan and the adoption of rules and regulations for administering the Plan shall be made by the
Committee in its sole discretion, subject to any required approval thereof by the Board or its compensation committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.04. The
Plan shall be administered by the Committee. Subject to the provisions of the Plan, the Committee shall have the authority, in its discretion
and on behalf of the Company, to (i) designate Participants, (ii) determine the terms and conditions of Awards, (iii) interpret the Plan,
(iv) prescribe, amend and rescind any rules and regulations relating to the Plan, and (v) to make all other determinations and findings,
including factual findings, deemed necessary or advisable for the administration of the Plan. Unless otherwise expressly provided in the
Plan, all designations, determinations, interpretations and other decisions made in good faith by the Committee under or with respect
to the Plan or any Award shall be final, binding and conclusive on all Participants. Unless otherwise expressly provided in the Plan,
decisions of the Committee shall be final and binding on all parties who have an interest in the Plan.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>III.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DETERMINATION
OF PARTICIPANTS</B></FONT></TD>
</TR></TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.01. The
following individuals (each, a &ldquo;<B><I>Participant</I></B>&rdquo;) will participate in the Plan on the following basis:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) The bonus potential for
each of Company&rsquo;s President, Chief Revenue Officer and Chief Content Officer (collectively, the &ldquo;<B><I>Executive Officers</I></B>&rdquo;)
shall be allocated to the achievement of the performance criteria for each Fiscal Year as set forth in the Performance Goals Schedule,
each with a specified weighting; provided, that the Committee shall have full discretion to change the weighting of the components of
such performance criteria as they determine based on the recommendation of the Company&rsquo;s President. Such performance criteria shall
be based on achievement of specific corporate objectives relating to Company initiatives regarding revenue, Adjusted EBITDA, the Company&rsquo;s
stock price and the achievement of such other Company key operating metrics as the Committee determines, subject to the Board&rsquo;s
or its compensation committee&rsquo;s final approval of any such Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) The bonus potential for
the individuals set forth on <U>Schedule II</U> attached hereto shall be allocated to the (a) financial results of the Company, (b) achievement
of Company key operating metrics approved by the Board of Directors based on the recommendation of the Committee, (c) achievement of such
person&rsquo;s approved individual goals based on the recommendation of the Committee for the applicable Fiscal Year and (d) achievement
of such other objectives as the Committee determines, each with a specified weighting as determined by the Committee based on the recommendation
of the Company&rsquo;s President, subject to the Board&rsquo;s or its compensation committee&rsquo;s final approval of any such Awards.
The Committee shall approve all individual goals based on the recommendation of Kit Gray, so long as he is serving as an executive officer
of the Company. Awards may be granted to Participants selected by the Committee in its sole discretion; provided, that the Executive Officers
shall be mandatory Participants under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.02. Except
as provided below and except as otherwise provided in any employment agreement, employment offer letter or severance agreement between
the Company (or a subsidiary thereof) and a Participant, if a Participant does not continue in the employ of the Company or one of its
subsidiaries through the last business day of the applicable Fiscal Year (the &ldquo;<B><I>Bonus Qualification Date</I></B>&rdquo;), then
such Participant will not be eligible to receive a bonus under the Plan. However, the following special partial payment provisions shall
be in effect:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)  Should
the Participant&rsquo;s employment terminate prior to the Bonus Qualification Date as a result of death or permanent disability (as defined
below), then that individual or such individual&rsquo;s estate shall be entitled to a pro-rated portion of the bonus such individual would
have earned, based on the Company&rsquo;s actual performance for the applicable Fiscal Year, had such individual continued in the Company&rsquo;s
employ through the Bonus Qualification Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)  A
Participant who is on a leave of absence or whose employment terminates after the start of the applicable Fiscal Year but whose leave
of absence ends or whose employment recommences prior to the Bonus Qualification Date may remain eligible at the discretion of the Committee,
and the Committee may provide that individual with a pro-rated portion (based on period or periods of active employment during such year)
of the bonus such individual would have earned, based on the Company&rsquo;s actual performance for the applicable Fiscal Year, had such
individual remained continuously in the Company&rsquo;s employ through the Bonus Qualification Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.03 For purposes of the Plan:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.  A
Participant shall be considered an&nbsp;&ldquo;<B><I>employee</I></B>&rdquo;<B>&nbsp;</B>for so long as such individual remains employed
by the Company or one or more corporations or limited liability companies that are a subsidiary of the Company at all times during the
applicable Fiscal Year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.  Each
corporation (other than the Company) or limited liability company in an unbroken chain of corporations beginning with the Company shall
be considered to be a&nbsp;&ldquo;<B><I>subsidiary</I></B>&rdquo;&nbsp;of the Company, provided each such corporation or limited liability
company (other than the last corporation or limited liability company in the unbroken chain) owns, at the time of determination, stock
possessing more than fifty percent (50%) of the total combined voting power of all classes of stock in one of the other corporations in
such chain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C.  Unless
defined otherwise in any employment agreement, employment offer letter or severance agreement entitling the Participant to a full or pro-rated
bonus upon a disability termination,&nbsp;&ldquo;<B><I>permanent&nbsp;disability</I></B>&rdquo;&nbsp;shall mean the Participant&rsquo;s
inability to engage in any substantial activity necessary to perform the duties and responsibilities of his position with the Company
(or any subsidiary thereof) by reason of any medically-determinable physical or mental impairment which can be expected to result in such
individual&rsquo;s death or which has lasted, or can be expected to last, for a continuous period of not less than twelve (12) months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D.  In
no event shall there be any duplication of bonus payments under this Plan and any employment agreement, employment offer letter or severance
agreement between the Company (or any subsidiary thereof) and a Participant that provides such individual with a stated bonus or bonus
formula for a particular year or includes an annual bonus payment as part of a severance pay formula thereunder. Accordingly, in order
to avoid any such potential duplication, such Participant - in a situation implicating duplicative payments - shall only be entitled to
receive the annual bonus amount to which he may otherwise be entitled under his or her employment agreement, employment offer letter or
severance agreement based on the terms and conditions set forth therein and shall not be entitled to any duplicative bonus payment under
the Plan. However, the accelerated vesting of any outstanding equity awards held by the Participant under any of the Company&rsquo;s stock
plans, including any outstanding stock options, restricted stock or restricted stock unit awards, performance stock unit awards, or the
extension of any exercise periods for such stock options, shall not be deemed to constitute a bonus payment for purposes of this Section
3.03D.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>IV.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>BONUS
AWARDS</B></FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.01. The
following provisions shall govern the calculation and payment of the individual bonus awards that become payable under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The
individual bonus award payable under the Plan to the applicable Executive Officer for the applicable Fiscal Year shall be payable in cash
and/or direct issuances of Common Stock (or RSUs), in such amounts and based on the percentages and amounts and based on the allocation
between cash and Common Stock as set forth on the Performance Goals Schedule) on the Bonus Payment Date (as defined in Section 5.01),
with the bonus amount to be determined on the basis of the performance of the Company and the achievement of the performance criteria,
as applicable, to which the bonus potential for that Participant has been allocated in accordance with Section 3.01. Any bonus award under
the Plan payable in stock shall vest one (1) month after the Board approves such award; provided, that the Committee shall have the right
to delay the&nbsp;settlement but not vesting of any RSUs awards under the Plan in the event such delay is more advantageous&nbsp;for the
recipient from a tax perspective. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The
individual bonus award payable under the Plan to each Participant (other than the Executive Officers) for the applicable Fiscal Year shall
be payable in cash and/or direct issuances of Common Stock (or RSUs) on the Bonus Payment Date, with the bonus amount to be determined
on the basis of the performance of the Company and the achievement of the performance criteria or divisional or departmental goals, as
applicable, to which the bonus potential for that Participant has been allocated in accordance with Section 3.01.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.02. The
following provisions shall govern the calculation of the levels at which the Company&rsquo;s revenue targets and target Adjusted EBITDA
(as defined in the Company&rsquo;s Financial Statements (as defined in Section 4.03)) are attained for the applicable Fiscal Year and
the determination of the bonus amounts based on those calculations:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)  The
actual level at which revenue for the Company has been attained for the applicable Fiscal Year will be determined on the basis of the
revenues to be reported in the Company&rsquo;s Financial Statements for such applicable Fiscal Year and will be calculated, for purposes
of the Plan, in a manner consistent with the methodology utilized by the Committee in establishing the Company&rsquo;s revenue targets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)  In
determining the actual level at which Adjusted EBITDA for the Company has been attained, Adjusted EBITDA will be determined consistent
with the Company&rsquo;s methodology for calculating Adjusted EBITDA for financial reporting purposes for the applicable Fiscal Year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)  In
the event the Company acquires other companies or businesses during the applicable Fiscal Year, the financial performance of those acquired
entities shall not be taken into account in determining whether the revenue targets or Adjusted EBITDA targets for the Company for the
applicable Fiscal Year have been achieved, unless otherwise determined by the Committee and approved by the Board or its compensation
committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)  Should
the Company sell, divest or spin off a business during the applicable Fiscal Year and the financial performance of such business was taken
into account in establishing the revenue targets and Adjusted EBITDA targets set forth in the Performance Goals Schedule (or such other
performance criteria), then for the purpose of determining whether the revenue targets or Adjusted EBITDA targets for the Company for
the applicable Fiscal Year have been attained, the revenue and Adjusted EBITDA calculations for the Company shall be made (1) by taking
into account the actual revenue and Adjusted EBITDA performance of the divested business during the portion of the applicable Fiscal Year
preceding the closing of such sale, divestiture or spin off and (2) for the post-closing portion of the applicable Fiscal Year, by prorating
the pre-closing actual revenue and Adjusted EBITDA performance of the divested business during the portion of the applicable Fiscal Year
preceding the closing of such sale, divestiture or spin off, for the remainder of the appliable Fiscal Year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.03. The
Committee shall, within fifteen (15) calendar days following the filing of the Company&rsquo;s Annual Report on Form 10-K for the applicable
Fiscal Year, determine and certify on the basis of the Company&rsquo;s financial statements for such Fiscal Year as publicly reported
by the Company in connection with its earnings release related to the applicable Fiscal Year (the &ldquo;<B><I>Financial Statements</I></B>&rdquo;),
the actual level of attainment for revenue and Adjusted EBITDA for the applicable Fiscal Year. Any Common Stock price targets shall be
determined and certified by the Committee, subject to approval of the Board or the compensation committee thereof. Such certification
shall be included as part of the formal minutes of the meeting at which such determinations are made. On the basis of such certification,
the Committee shall determine the actual bonus award for each eligible Participant. However, the Committee, in making such determination,
shall not award a bonus in excess of the dollar amount determined for the Participant on the basis of the bonus potential established
for the particular levels at which revenue, Adjusted EBITDA, Common Stock price and any other performance objective for the applicable
Fiscal Year are in fact attained unless the Committee determines that it is in the best interests of the Company to do so. In the event
that revenue, Adjusted EBITDA and/or Common Stock price falls between two specified levels set forth in the schedule approved by the Committee,
the resulting bonus (or percentage thereof) amount shall be determined based on the lower of those two points. In no event shall the bonus
awarded to any Participant exceed the maximum dollar limitation of Section 4.05.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.04. Except
as otherwise provided in Section 3.02, no Participant shall earn or accrue any right to any portion of a bonus award hereunder until the
Bonus Qualification Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.05. In
no event shall the actual bonus amount payable under this Plan to all Participants for the applicable Fiscal Year exceed the dollar amount
of One Million Six Hundred Eighty Nine Thousand dollars ($1,689,000), as may be subsequently adjusted by the terms of this Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>V.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>PAYMENT
OF BONUS AWARDS</B></FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.01. The
actual bonus to which each Participant becomes entitled based on the certified level at which the revenue, Adjusted EBITDA and Common
Stock price targets and such other performance objectives targets determined by the Committee are actually attained for the applicable
Fiscal Year shall be paid in cash and/or direct issuances of Common Stock (or RSUs), subject to the Company&rsquo;s collection of all
applicable federal, state and local income, employment and payroll withholding taxes and the terms of the EIP. Except as otherwise provided
in Section 3.02, the bonus payments shall be made not later than the fifteenth (15<SUP>th</SUP>) day of the third month following the
end of the applicable Fiscal Year for which the Bonus is earned and awarded, with the actual payment date to constitute the&nbsp;&ldquo;<B><I>Bonus
Payment Date</I></B>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>VI.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>GENERAL
PROVISIONS</B></FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.01. The
Committee may at any time amend, suspend or terminate the Plan, provided such action is effected by written resolution, and subject to
approval of the Board. Moreover, the Committee reserves the right to amend, modify or restate this Plan as may be necessary or appropriate
to avoid adverse tax consequences under Section 409A of the Internal Revenue Code of 1986, as amended (the &ldquo;<B><I>Code</I></B>&rdquo;),
and subject to approval of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.02. No
amounts awarded or accrued under this Plan shall actually be funded, set aside or otherwise segregated prior to payment. The obligation
to pay the bonuses awarded hereunder shall at all times be an unfunded and unsecured obligation of the Company. Plan participants shall
have the status of general creditors and shall look solely to the general assets of the Company for the payment of their bonus awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.03. No
Participant shall have the right to alienate, pledge or encumber his/her interest in this Plan or any bonus payable hereunder, and such
interest shall not (to the extent permitted by law) be subject in any way to the claims of the employee&rsquo;s creditors or to attachment,
execution or other process of law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.04. Neither
the action of the Company in establishing the Plan, nor any action taken under the Plan by the Committee, nor any provision of the Plan,
shall be construed so as to grant any person the right to remain in the employ of the Company or its subsidiaries for any period of specific
duration. Rather, except as otherwise provided in any employment agreement or employment offer letter between the Company (or a subsidiary
thereof) and a Participant, each employee will be employed &ldquo;at-will,&rdquo; which means that either such employee or the Company
may terminate the employment relationship at any time for any reason, with or without cause, subject in each case to any applicable benefits
that may become payable under any employment agreement or employment offer letter between such person and the Company or any of its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.05. The
Plan shall be administered, operated and construed in compliance with the requirements of the short-term deferral exception to Section
409A of the Code and Treasury Regulations Section 1.409A-1(b)(4). Accordingly, to the extent there is any ambiguity as to whether one
or more provisions of the Plan would otherwise contravene the requirements or limitations of Section 409A of the Code applicable to such
short-term deferral exception, then those provisions shall be interpreted and applied in a manner that does not result in a violation
of the requirements or limitations of Section 409A of the Code and the Treasury Regulations thereunder that apply to such exception.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.06. No
employee, officer, Participant or any other person shall have any claim to be granted any Award under the Plan, and there is no obligation
for uniformity of treatment of Participants or beneficiaries of Awards under the Plan. The terms and conditions of Awards need not be
the same with respect to each Participant. Any Award granted under the Plan shall be a one-time Award which does not constitute a promise
of future grants. The Company, in its sole discretion, maintains the right to make available future grants hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.07. The
Company shall be authorized to deduct and withhold from (i) any Award granted, (ii) any compensation or other amount owing to a Participant
under the Plan, or (iii) with the consent of any Participant, from any other compensation owed to such Participant, any amounts required
to be deducted and withheld in respect of an Award under the provisions of any applicable federal, state and local statute, law, or regulation.
The Committee may condition the delivery of Shares or other benefits upon satisfaction of all applicable withholding requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.08. Nothing
contained in the Plan shall prevent the Company from adopting or continuing in effect other or additional compensation arrangements, and
such arrangements may be either generally applicable or applicable only in specific cases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.09. None
of the rights, benefits, obligations or duties under the Plan may be assigned or transferred by any Participant. Participation in the
Plan does not give a Participant any ownership, security or other rights in any assets of the Company or its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.10. The
grant of an Award shall not be construed as giving a Participant the right to be retained in the employ of, or to continue to provide
services to, the Company or any of its affiliates for any specific duration. Further, the Company or any affiliate may at any time terminate
a Participant&rsquo;s employment, free from any liability or claim under the Plan. The receipt of any Award under the Plan is not intended
to confer any rights on the receiving Participant except as set forth in the terms of the Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.11. (a) The
validity, construction and effect of the Plan and any rules and regulations relating to the Plan and any Award shall be determined
in accordance with the laws of the State of Delaware, without application of the conflict of laws principles thereof. If any
provision of the Plan or any Award is or becomes or is deemed to be invalid, illegal, or unenforceable in any jurisdiction, or as to
any person or Award, such provision shall be construed or deemed amended to conform to applicable laws. The Plan shall be unfunded.
Neither the Plan nor any Award shall be deemed to require the Company to deposit, invest or set aside amounts for the payment of any
Awards under the Plan. To the extent that any person acquires a right to receive payments from the Company pursuant to an Award,
such right shall be no greater than the right of any unsecured general creditor of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) All
claims, disputes and other matters in question arising out of or relating to this Plan shall be resolved by binding arbitration before
a panel of three arbitrators, one of whom shall be selected by the Participant&rsquo; representative, one of whom shall be selected by
the Company, and the two arbitrators so selected shall select the third arbitrator, in each case selected from Judicial Arbitration and
Mediation Services, Inc. (&ldquo;JAMS&rdquo;), in Los Angeles County, California. In the event JAMS is unable or unwilling to conduct
the arbitration provided for under the terms of this paragraph, or has discontinued its business, the parties agree that the arbitrators
shall be selected otherwise in the same manner set forth in this Section but substituting the American Arbitration Association, or its
successor (&ldquo;AAA&rdquo;), in Los Angeles County, California, for JAMS. Notice of the demand for arbitration shall be filed in writing
with the other party to the dispute and with JAMS (or AAA, if necessary). In no event shall the demand for arbitration be made after the
date when institution of legal or equitable proceedings based on such claim, dispute or other matter in question would be barred by the
applicable statute of limitations. The arbitration shall be subject to commercial rules and procedures used or established by JAMS, or
if there are none, the commercial rules and procedures used or established by AAA. Notwithstanding anything to the contrary in the JAMS
(or AAA) rules and procedures, the arbitration shall provide for (i) written discovery and depositions adequate to give the parties access
to documents and witnesses that are essential to the dispute and (ii) a written decision by the arbitrators that includes the essential
findings and conclusions upon which the decision is based. Subject to Section 6.11(c), the parties shall bear their own costs and attorneys&rsquo;
fees incurred in conducting the arbitration, and shall split equally the fees and administrative costs charged by the arbitrators and
JAMS (or AAA) unless required otherwise by applicable law. Any award rendered by JAMS (or AAA) shall be final and binding upon the parties,
and as applicable, their respective heirs, beneficiaries, legal representatives, agents, successors and assigns, and may be entered in
any court having jurisdiction thereof. Any arbitration hereunder shall be conducted in Los Angeles County, California, unless otherwise
agreed to by the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) In
the event of any arbitration or litigation concerning any controversy, claim, or dispute arising out of or relating to this Plan, the
prevailing party shall be entitled to recover from the non-prevailing party reasonable expenses, attorneys&rsquo; fees and costs incurred in
connection therewith or in the enforcement or collection of any judgment or award rendered therein. The &ldquo;prevailing party&rdquo;
means the party determined by the arbitrators or court, as the case may be, to have most nearly prevailed, even if such party did not
prevail in all matters, not necessarily the one in whose favor a judgment is rendered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.12. Except
as explicitly prohibited by law, this Plan is provided at the Company&rsquo;s sole discretion, and the Board or the compensation committee
may modify, amend or terminate it (other than with respect to the Executive Officers) at any time, prospectively or retroactively, without
notice or obligation for any reason, subject to obtaining any necessary shareholder approval as required by law, regulation or listing
exchange requirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.13. In
the event that, after the Bonus Payment Date, discovered fraud or misrepresentation (as determined by the Board) should result in a need
for the Company to restate its annual financial statements for the applicable Fiscal Year in a manner that reduces the Adjusted EBITDA,
revenue or other figures that were used to determine the amount available for distribution under the Plan, then Participants who have
received distributions under the Plan in excess of the amounts they would have been entitled to receive, but for the fraud or misrepresentation,
shall be liable to repay such excess to the Company, without interest, on demand. Each Award (whether vested or unvested) shall be subject
to such recovery or clawback as may be required pursuant to any applicable federal or other law or regulation, any applicable listing
standard of any national securities exchange or system on which the Common Stock is then listed or reported or the terms of the Company&rsquo;s
recoupment, clawback or similar policy as may be adopted from time to time by the Board or its compensation committee, which could in
certain circumstances require repayment or forfeiture of Awards or any shares of Common Stock or RSUs or other cash or property received
with respect to the Awards (including any value received from a disposition of the shares of Common Stock or RSUs acquired upon payment
of the Awards).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.14. All
Awards of Common Stock to be issued pursuant to this Plan shall be deemed issued and outstanding only as of the related Award date of
such consideration, and except as set forth herein, no Participant shall be entitled to any dividend or distribution declared by the Company
in respect of any Awards of Common Stock the record date for which is prior to such payment date or any RSUs which have not been settled
on or prior to such record date. This right of a Participant to such Common Stock or RSUs shall not represent an ownership interest in
the Company unless and until such Common Stock or the Common Stock underlying the RSUs is actually issued and shall not entitle any Participant
to any rights common to any holder of any equity security of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.15. For
all purposes of this Plan, the share amounts of Common Stock and RSUs shall be adjusted to reflect appropriately the effect of any stock
split, reverse stock split, stock dividend (including any dividend or distribution of securities convertible into or exercisable or exchangeable
for Common Stock), reorganization, recapitalization, reclassification, combination, exchange of shares or other like change of securities
with respect to Common Stock occurring or having a record date on or after the Effective Date and prior to the related Award date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.16. This
is the full and complete agreement between the Participants and the Company with respect to their incentive bonus compensation for the
applicable Fiscal Year and the related service period through the Bonus Qualification Date. This Plan does not supersede, but is supplemental
to, any provisions of any employment agreement or employment offer letter to which any of the Participants in this Plan may be a party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.17. As
a condition of receiving any Award, each Participant agrees to execute the Participant Acknowledgment, attached hereto in the form of
Schedule III, and until the Company receives a fully executed Participant Acknowledgment from such Participant in such form as reasonably
acceptable to the Company, any Award issued to such Participant shall be deemed null and invalid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[***]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SCHEDULE I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>see attached</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SCHEDULE II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any employee or officer of the Company other than
the Executive Officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE III</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Form of Participant Acknowledgment</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Participant acknowledges receipt of a copy
of this Notice and Courtside Group, Inc.&rsquo;s (the &ldquo;<B><I>Company</I></B>&rdquo;) 2023 Annual Bonus Plan (the &ldquo;<B><I>Plan</I></B>&rdquo;),
dated as of ___________ ___, 2023 (and if applicable, the Award Agreement) and represents that he or she is familiar with the provisions
hereof and thereof, and hereby accepts any Awards awarded to the Participant subject to all of the terms and provisions hereof and thereof.
The Participant has reviewed this Notice and the Plan (and if applicable, the Award Agreement) in their entirety, has had an opportunity
to obtain the advice of legal counsel prior to executing this Notice, and fully understands all provisions of this Notice and the Plan
(and if applicable, the Award Agreement). The Participant hereby agrees that all questions of interpretation and administration relating
to this Notice and the Plan (and if applicable, the Award Agreement) shall be solely resolved by the Committee and the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Participant hereby acknowledges that he or
she has had the opportunity to review with his own tax advisors the tax consequences of receiving this Notice and the Plan (and if applicable,
the Award Agreement), and the transactions contemplated thereby, including any U.S. federal, state and local tax laws, and any other applicable
taxing jurisdiction, prior to executing this Notice. Participant attests that he is relying solely on such advisors and not on any statements
or representations of the Company or any of its agents or affiliates. Further, Participant hereby acknowledges and understands that he
(and not the Company) shall be solely responsible for his or her tax liability that may arise as a result of receiving any Award (and
if applicable, the Award Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">PARTICIPANT:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Signature)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; white-space: nowrap; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Print Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dated:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">12</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>podc-20230809.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 86o5s7xRiXhun8uDb31cWauN+aPty5BxCZkxsmx/HZkany4tvi5+eS+ANCAmMXgA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:podc="http://courtsidegroupinc.com/20230809" elementFormDefault="qualified" targetNamespace="http://courtsidegroupinc.com/20230809">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://courtsidegroupinc.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="podc-20230809_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="podc-20230809_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>podc-20230809_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>podc-20230809_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://courtsidegroupinc.com/role/Cover" xlink:href="podc-20230809.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://courtsidegroupinc.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140715393976880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 09, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  09,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">333-269028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">COURTSIDE GROUP, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001940177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">35-2503373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">335 N. Maple Drive Suite 127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Beverly Hills<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">858-0888<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>ea183613-8k_courtside_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="podc-20230809.xsd" xlink:type="simple"/>
    <context id="AsOf2023-08-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001940177</identifier>
        </entity>
        <period>
            <startDate>2023-08-09</startDate>
            <endDate>2023-08-09</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="AsOf2023-08-09">0001940177</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="AsOf2023-08-09">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="AsOf2023-08-09">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2023-08-09">2023-08-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2023-08-09">COURTSIDE GROUP, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2023-08-09">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2023-08-09">333-269028</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2023-08-09">35-2503373</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2023-08-09">335 N. Maple Drive Suite 127</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2023-08-09">Beverly Hills</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2023-08-09">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2023-08-09">90210</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2023-08-09">310</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2023-08-09">858-0888</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2023-08-09">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2023-08-09">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2023-08-09">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2023-08-09">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2023-08-09">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2023-08-09">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0    (  B(#U>7BKL<P
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MCEYG>O\P>=0>6N=6RKV'5[+E&''\GN4/4$L#!!0    (  B(#U<D'INBK0
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ "(@/5_[=I'KN    *P(  !$
M             ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
M"(@/5YE<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    "  (B ]7@"4O&!<$  !E#P  &
M    @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
M"(@/5Y^@&_"Q @  X@P   T              ( !6@P  'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    "  (B ]7EXJ[',     3 @  "P              @ $V
M#P  7W)E;',O+G)E;'-02P$"% ,4    "  (B ]7JL0B%C,!   B @  #P
M            @ $?$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ "(@/
M5R0>FZ*M    ^ $  !H              ( !?Q$  'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ "(@/5V60>9(9 0  SP,  !,
M         ( !9!(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^
) @  KA,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>20</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea183613-8k_courtside.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://courtsidegroupinc.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ea183613-8k_courtside.htm">ea183613-8k_courtside.htm</File>
    <File>ea183613ex10-1_courtside.htm</File>
    <File>ea183613ex10-2_courtside.htm</File>
    <File>podc-20230809.xsd</File>
    <File>podc-20230809_lab.xml</File>
    <File>podc-20230809_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="20">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea183613-8k_courtside.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 20
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ea183613-8k_courtside.htm"
     ]
    },
    "labelLink": {
     "local": [
      "podc-20230809_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "podc-20230809_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "podc-20230809.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 20,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "podc",
   "nsuri": "http://courtsidegroupinc.com/20230809",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea183613-8k_courtside.htm",
      "contextRef": "AsOf2023-08-09",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://courtsidegroupinc.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea183613-8k_courtside.htm",
      "contextRef": "AsOf2023-08-09",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://courtsidegroupinc.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001213900-23-067848-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-23-067848-xbrl.zip
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MH1#L4+@BX [XU"YT'LIL?JU8*4J E[?G3)<D/6>FXR;3=69PD00,\8;O8W:
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MB%,K$]PGU1=N"/?(33*6!6I+D9)A,#0C?HQYQ8Q"3/;V9*4+)=-@^@ 6A:1
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M[4\#^CG(>2='F_^"^V DCJ$@2UA(?KS!^)?^JG"3@>;=>,"*V]ZZXJ?E:)2
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MI)P797[?$9\&<"L8,0/4Q;]!LUJ_M787U4CB VJ&RL=&Z"I^0E4SK!:,GT+
MXXS\)F ML"G#R<\TR?!IWC&IAZC58$5U.\&J16:-I^#E*;*F1?>&ZJ=4YL?%
MX#Z2EK6LCUA$/>,;YA(E-.1)4C'H?+:]Q8>"3NH1*FJDQQ-"6#.HBJ;>W+;#
M)"5L4Z@-89QMSC1=R_"L54,6%^E1XD%BWQ7GCA,@"L\,4W><,IS0RG1X]?FZ
MXP>G"8=BV)0AEKCBT[C:Q(\NYF3G7/F:9@MD2*W4B%+K]G+ER=ZU&S&%&W&J
M $97E94]IZO)RI$*-@\RU1_(5PZA3P&6R'.2_QXL2DY2E,3[U)?&4MJ(5K_Y
M0HIPQS!CU2XKP/EIFNMD71Z(6.]@OB'%3'*P$7-*N]"I(@@2$OA2FVN#0%C4
MV>_[0MTF=.G63"?Y3L/TRJ7[,?^]"'+=-"<<I'DN-,Z:;DHUX82$3=?8750?
M-N!_-;J&))&BEZ'JPA;>L<OS%ZKK>U=M;_TC0Q4*+ /X7W%W48T?80%?TA\Y
MPSVX"54_E380XWR%,RWX[B/0-'/#6C^'5ST5W3Y,%T#PXOEJ\[HN2UQ_FQ='
M!?8$RQH*XZ4S@VFC';0E6C2Y0M@E02V@*,S53W$A?D!) ^JYX65A(\4Q^0PL
M$E3>>CZDWUQ+8KVC<C'^;;>%(?"6BD!2R:];NB6(@QF84 TY6XG08W]=5VTP
MV>>27U!0IQ.<Z )HB/LM+4J'T#HC)PWV2%:Q\'.1(Z)RK(EDTGR$O%_3C&/.
M-)Y&G_V WK<:O/I^S8.U;X(E(7%0=FAYD%H:E /WM 3!GK51@4BUZ71))6_<
MA0N]L@8^<G @[2OGIL"G! *)4*Z7O?M0$391Y1NTX&>#QI]S87\KDZ]8;I,0
ML@31GU9N2@ "O]]A387%:&W%DWZG^=SWPN=0@A!B'XBB+$3>O9$JV WBY+3:
M6K^1:$)>(;DTWBV7>E0S> )%%QF*^KO&E3Y<9-M89^-QS6Y'1&=K-=CK4X/@
MEN=S@H'=":EO%.F954U+D09$ )!1*ML^);PJ?809)9-B852_:Q9*J3#&[8FV
M(NH"8J?:K^!;2(!DJ?>W\F,3O$_SVBDT69B*VH.AS]WC6"C&,R-L,%K!"+3:
M!N^U1V7 J"+">;2+NO2!693HY%%@?(T \$#H7J-J6N:_D&&YJ',*%#+LA\7<
M(A:. !:3 #:]X_:F>VGRHQL??4Z3GT\^2I]&_X"HWKQ66T02%93'O0=(13<]
M>380'K%ETMO<V*!T=#Z%39KQ;G*19PE%7H77A<'C8:<YEN$,'S'/2;+9TS)'
M;CDC;D3&M^P]\#KD_[(E;.,WLO4<E^LM59+ T=[:>=0M[EF59Q#OU.H]D@!7
MVZLD/P'ZA&5_U%5@L;0XM RM)1U2HTM&.J^T5Z)51<T%Q,,1T\XN@]RPE9EK
M[H%.Z)B*:3M'6-E8AU:3LJ\DLT/"QE//*A0,R<@%;XP$V?#J/,-!2XZUO3IZ
MGVJW<<,9>A&,&A2*? Z[!!HQZ]>A$)7]D+#<.67][MAT#4:2\3H<G]-N\C&#
M/R>'9T5UD;7-IWR)G9::?^.5J@I03SZ>N]$Y'K=Y)'G[]B1-]O>_?Y@< HDN
M?"3M< 9\?Y3!2KZ'A?Q85!7P$)0._ZSJ3^$GC"@]>J*[9\*ENG_\^=M;TC,J
M&ZASPXT@IY\ 3E*=+[U]OL ]Q7S/13UBC8N2_LOQL(=BS8[>,;%[E1C-DV\Q
M&HG1//D6H_G=4O(/>X3^_%/>C%Q1<--9420','!R@]05 VY$NCRF!9*M1. <
MG'12<&E-/Q\%M03KT \0 Y'G<3@Q*_!];NYC05&OO +J/K1N!8E?  CD_@KZ
M.'@]3&I<S^:UB$<J-/[T36REHR'!<?#/*>DJ[$I8HC4^.B>T#^XXF9HNK12]
MJ>8FL 5V4KJJ!?HP0'P5=;P5/(ZJT\T2U'TV8-M.(;FTMNQ4BTL)F*\8[V:=
M>>>&WTV_,6FG"5=4"\V@S4'U,GVDU=LB ]'.2,"ML1&WIDO=""O=U@N^!*4B
MH)OXF8T3Q"A>.]HDA7N4432#3*M%:7+A":4<F% :OIOK^V%%V1)S/&V51M B
M39/8SVAVY=2^I<&ZBL: X5,404K<4PMSP9:-J=9#C,-%*;I@?/G+D&@('*C$
M4&1HGT*_%ON\1_[:]P.-GX#,3DU84)\LJ^ZQ4%6"]L>(&DOAL.MQ(M,!9]!9
MSBA]4@5#M1&$%2PCFKA&AT1[4<[@?/![+PC$_@]\TYN]Y+!)%HWIB1IW]R _
M7L#54OVUF]IE\F0XQBD1,)\]*4TG BF@UZT9NH'H'<=W&[1@N=8AD K<&=\X
M0=$0NJLV+*?+42(><<?T0;3Q3U>Y5AD/-)A7%A^,H<"0T6*7CZHNP>+M !_I
M@(V@[#.EX>F@#7U>H6W:2O![IX/UA.88C-7*$7D5OM \7:  12/S[7D"8(CQ
MYEBX#_T G.%?8 XW8T5Y"XFI^F%@KODOVY6M(.$Q0]N/NGQW$]A2ZY_B=%YI
MBR2%)+&?^Y#KW\1E3C#@R@_<)W%RB4M6 B3&;YSZ2K9$RN,X0T%G1.'/*"-#
M6(!GE!;7*N8+(LEE6'$0LA?I7O)6U-K)@GP(+1IMU2AT3(9[+M[BMQ5,!?*W
M(,+L$PBS;/*D\W2BBGAF%I^)9M33I-RB)J2H*JX]==Q !;!U\N2N7[YB:?8V
MF*"_,LI-YZR,?\DIPCK8VBV8STB2] F^VC0Z\-"8*"!"\:S/N.A! <L!4"S-
M'QWO!OS$)7+R]F55%Q&09]0WQO:+P2O@H^[H5*0+ART5G$7T5_@Q A\+%,_-
M,0)@FWYU7X5F+QOJT""S:Q%X>B8A.YV;,L:X.9&>W1M;(6P%I55*V12 NO45
M-JK#&J5&4/3B&@XAY#T.0Z]&K1(5RK\^T$?$=EEJT&\!2US,=H#,PAP=;6-8
M/DM9>9.8N$V44._=%12>B<[N@F"6'$$75]SX'B&<V70(CDT3I&D6]44NC<1L
M8GW=B\IKEL+3;@6R?2Z"VQO(\UU1J;#[E '*I4?.SG@73;1DI]NS9S>USSV1
MA\+\XNZ6!YKD+SZS]P=9-2;V[JHIM>JXM0QF:&O(43BP-4<A1>%$RB@DZXN2
M=L3WS(E1+1?TB-.7;W4H(:#;X^3J^H1HJ9\5:PYKD1OL)$&^92Q&3LDWO"C1
M6&F"SDL#U(0U3?),L@8]D' _X5K+/GE9*$W')O:A43*R+"A4P-N28NQ*4L[2
MX'(WPGP8_'C5%?<W+L=N,T6+(IWJKF$'<65-R#94Q$/?J@MO4(C+^>_UL95J
MZL1U[WV@E4=3%$4_< X0P&@-<+*47Y99RD!TUOO7J>R(-5U, ;]/3FI*X3@!
M'DI7^W4U8@[U(S5  <8)O]0.SGOS\<2W'MXAZUA"PZX1XWZR0$!R?HU[J(22
M9JXQ)B'";-;ORK3.YK ;?$ Y9KD0UB4"R=9Z4AD8,+RVW52B ^%3L#]Q794P
M!*XA&Q$XO*!#2/E@&O5/P^DIC,P,+J3#AU1%8Z N!W95F_?X2BQ*1I1N,71J
MW1#RP"O\M#IY$%0VS)=M..@SV!SF>C;L^RGAI!8XA=NR"M2#&:OF-VD2K/6*
M#BWFWHO_>7[\XJ-^.?DOM=WQ\P?'+_[W#[L5UYSV*J[ROWQSE8NK_"_?7.5?
MC8;76OBF(R5E,'CY:NJ8XGP6:V5P$@ZW>COGC,A1AM T'-//QFG"/Y/;F9+V
M)>> W8JQG5)UO'3.:*P"%A;I$#>V7_2_CR0$]M*?QLL7MS5#-/;IX<NW1\FK
MH[=O/YX<OCI^]^:O]Q[>HW^?'+Y^K?^^]OR7^;@]?TJU>YZ%C(!19_,&+I/^
M=(_NP//3#SH!==8=9852#URT>WI/3E_[O8$?_2^35^]QZ>_^>N\ ON[']^].
M[6KO3S)0$99/-ZV7GFWR7QQ_'NW3J_<_?SC]>/SZ*'GSX?W/)VER_.[5'F\>
M3O/"KN/!Z8??];=8JOKMB]>GY)2?//S3O>'OB9][_*>;_*J7\,[ QX19-TDN
M3Z6/;G9A#YH'":@I_P6LZ4V=+5$QN36*N<%ED]3D.8;W]0;G"GOS^]^74ZS1
M7T%J-SB-;UUZY[G+%UY\2 #Z@W[ %][]J[+76V"I'Q<N^6D$C"JKLUMEJ[=T
M6/'Z5Z_] 6EE+VY'];MA=3^:X0IFZ???S%(Q2[^_FV:I)9BOY3X!KO_??SM^
M>7R:'-ZHI?6[,+G7?O?SG\&N>?<C6#7O3H\/WQZ?_C--WKU_=__XW>G1AQ^/
M/AR]>W6TO77X[C58.W_'9]Z_2PX_?CQ^\^XG^%=R^.;#T1'^A&&0/_[67<-7
M<1B!'E !E2 <4H15"AZY=U3E:]71M=$I)$V35Q0+1KBF-W6UF(-A68[V$ O@
MM2L8&N^5Z6QIVT*B5<J.$>+DXJ3W[<,U'JA!(UICMXZU&_F<+2UZ'2>)F;ZU
M976I!?B.T[^H4H.Z670PM>!#0I%T:Z-_>T!2!?JM<TYJT\:>5'/!\2E*Z<%X
M*L&N2A:.9&!0I3:7I_A:5HP*P,B-U"EHB30/IJ59X=,IM)P4KJ6N;A(&[N\%
MUQ2,!3[G<#'%(I8?TN3@X<$C@E>4,'#*U5HYIY,AA&Y&M27Q69GXG'<<V8/[
MPCZW[[[F_=G?2X3]F!#H]M9QR?&CG+M$WB)+6;LKM^%XN\KT^[PU^PEMC&1)
M$%=(.CNSAY<KN#_)^QFU8\8,$X80B2X]7DJJ-62D7LIFP]M25N5][I$+M\7/
ME&1GDIKK7;"ALER"E7%-N231,@>2?V "9S[.LUJQKDP#@AUT_O&[Q;)[8?0N
MT@[8FZ)]6[-V$TN3Y C:%HJI8O$PU4!2S>Y(7AD9*A1T"\S:<2T6==@-Z2)1
MT]+@,$HM&[-/H5(VK:B(3U@A%=407BG1C3DOKC>^$HO6PKX);OC.X]UDZ;*:
M.OQBS#_D6,QZ$$#QX#%T08ID@$D.(CHF7,C"TD0R:A=-R+_65<1IG<%5+\*,
M4R6UI[FF7W/P$YO5<:ZLEV]I*&O#TV@#')$FU BV^B]#YT&EP;0\:EXAJ3_<
M1UCR1A4!#I^VO,=>,*:L8P'=)OE-I=1#B4:4OR0"SJ;F5H2]L+V%>)E1YKOO
MHRUI@PS;$%(37]H&PB=U-7$"QOVJ@IG^W,!E>9;L/WGR\"$<!5PN]^\]'ZOW
M72KQSWI9]@CS)>.<,ZG*"EEIG4RV"TGHCK.30J%W0^7 DEJ%3(,;OW*'9S?*
M.>AN=B#I;L! ],1OAJ!'1)\1",(D;:* 7;15O=3:/GB:,NXWOXIIM,05X,;4
M[H(P9QDKOHM<P3DH:RK@&?E&,>&O_1&T8$H*OL:JI8W&NB7K0J(\*P(KP,=]
M-_4.AY(U;&\]04RQ?DI1-S?)P][@E:8U93V=V.* 6< N6F8 K\5TJ&./VD",
MDEO+4CO[3\BKY[D+:$XK[VU ?%0NT6NPE 8>067P/<9 F=PARQH6XE!($G!G
MA2'$"8I/X*32P4[NOFV5P#=H!70RR;7A]1L1)VDN1O1@]DPGY9\U@W."^0;Y
M6<T)%';$^YP*TQIS+4)>X$_(ARM*"V)&>RD5$-KT' ?Q0^@(?H#P/A>KPNMR
MUW$-%^C'X=IVGU+HT^,G PM7E%,\Z="3%G6:,O'R/2IQ0("8AJDB)\0-8O-6
M>",AA0"OYINN(!=.(D1U#2T-64DAG2PP+UHE+I>L#FI(TOP6LWJY H0R3+GB
MF>1KFV,])V5N&L[^@%-R$8RUP63L!D0X G10-0H=@VUU;FDWIK< W>Q&YR7U
M$ 23)4.4C1HE$X@+8."<BXD[>_\<X^H;8.A0.%1-5FB]3EC/)1;,DN1WA1.^
M"$]/ZVS6I)+[U:14\TM)WMM;^$;TA?+5# %DQ+W=U(!9._2INF\4ZN?J;%XI
M:-N?Z&,9A0\MO)PP!A@_6'[9;&Q2&I[LJA=87%[-@,8034NO#K!@^2UG#B*J
M/=TA)%)XJ*/E]2UQ,-F;:M*BK9_:[:;.DA=<O=VDG,+=$%0";M6BR @!'LZ]
M*JKI$E^EFACXH<Y0 \0,Q1+L#T=-V*G[Z9@<"G1CI@OU#)BM3V43Z7EN3JK0
M#'Q,!N4VG)>J=[UN=M+_Q,M(4UQ'750"RD5%MY_Y"@RB7\!OL'G!,@6$]BRG
M3= D3&!6<P\0QZO4^9&27=TN-T@_!G->:8J:HG5A&1Z6OJOI)\ [9I*,D@E2
M.E,$K)>XAV=QFA=<@EY=&GDEF\FMPT&!5 "$-=-Q:UP8.1P$>V0FZ'YAU*NV
M%AV/"^L2J4CGHA3I;T/IW,52/58U\S'&[2:T(DPGI?=E(M\<!M=A8/+6K'7P
MPHO"315I*I8\P."P2>0MC6<>O R,K)GM=AC,CI4B@,ZQ,1T6 DUV:;F+">]/
MC)!/9N3%H@:O]-=20=PZ/&173M.@77:D8F1+1,J'5HP%Y4/[A.=--Y<<;M([
MD%C'Z#B=."[-Q'TZ5H:2'%(%'>WI#HT0%)0A]Q1#2D6/K4Q?C]R1"'M* !YT
MDED+:GOIEHVF7OF$<70WP/>Z\?VVNH]71)IT#,!O8ZE=W8J-2X(F;,4*I94;
M6$7J^XZ'&>7ZFY4K8R^FH8R6;;A0TND);:U^FE(C(B"7B6W1%!WQV$T<>V%]
M,RZ^5A>[7ANFJK,BRV=IIZT8]K.:RDQ9#=?5EU(D7,S)2@^VKB(O=;?R,'06
M8*[0,2Y@S@4JM-3MGN[<15S!1(M'%\&*A:1F&95IOXV6F%8GI9'YZ?W'SD)^
MFNY2HPX),JY259LB'Y.!+IZQSBL!JRLNP(D8A=:8_J8/-5587[IZ\_NOEMOY
M_55CP3\\2][/2==YB@M0^_ _)RQ\>/_7!(;W[V9@^&N1]37\] ==K9**7QD2
M,B L $^HEP8B4AT-I*T$_X-55]8Z)ZF*:MS1$V@P=;&0'<J5_SWP/HL!V;=]
M-%X9R972L]4)F\3D201&7>=GH+D61N_FXF-N; ^"_U\PSRC')X0YXD_C65Z"
M68:<\H(59% 0P9@A=Y[OG D/3H'.>3FA%(I8-OG;6P^V2-_>5$F$>V"V<C57
MUV@(E::%HXB^OK=[I(()=#FAR)&?C4K5?,2T(V&L]S,@G^ I3K6\SU@LV)J1
ME5]MP\8N)/S&81\0A16P* _=@@2L9ROW4K)+L52; *5M13+\V$KDAH]87!-4
M<CR(J][]MG5HFW]\&7<-9O (@W980(?Z#*N@L)\#83M?+>L#6)WR1(/PXE'L
MAU1\H\JRQ>%AEKNQ&$%OE.)7P;-@R%'_6W9V6:WIDW/S.!BT*BR6AF:D[,+*
MVLP[(J4 L3.28C\+I0O.#0DW T\SF^'#Z@I;'QMC+\5Q^*Y.T E-Z=E9SR S
M@2HXT<6(N>^:1WT@#'\3>VO8;@ZLAIU\0SM&?@[?/HT]1Q22Y9C3<->A[L<S
MO\@#-GC=Z^:4]2YL%O3]$GWUZFP0:!+O2*%JRLPJTC2G!$7LI'?CFDOBPH$F
M+KPV)W]G<Q4..%?![@7VYQ029FB?$<J@L7(_%&54HJ],D!$NZCHSH$:UH_:+
MA"XV<,FD[I5<RT3DI#0TYSE<XWR&$HG17-B;&#G"I0#[$J>0^$CP.#&?BEK$
M=UG0<)U]E,606'B-S/I+3AC>+*:<X"EA#,K(91:C8MB]6A+\D/!S9GWB9Y;X
M.JY+?L/??.S]1\B6%-YF>\N[T+N]Q,$L.-=6(&C%QD"KHI-T\M&,4XGW)LY,
M.T;M4Z+]-"CQ//,[<J:1D6\4(O3VIQIG2#T:K]<Z*2J1);2]R6L;/C''RI7K
MNA6<_E)Z+XMTT/#T27W;.[@@% (B])^&-->Z6F9%N[P_H<2.O.;N-HAQCML[
M=^@[31D;Y1+3^PJ^"MP.AQ/8M%5/0ZYA_*MW\Z2\1LPO((B%^5*RS/"_Z 8"
M=2V_R+@_N=R$E 53XXJB@SDV1HT;U/567%2]O4H[!@6+6]T>OI0Y8BQ@T%0@
M!WA+NU)*P^:K3PV7>S>$AC#) V22X6I0!*@K/PQS%!3#.-+'B$[B[H330B>W
MY%GY,Z* @H(I$N%12V-T.[.C;JP&G40UT3>[:X), 0T10Y8EPT,0A+_Y-W$A
M>8R-%&XKJ6@/"#I$S<9QQ98?,Q5Q8)6#JCPJ,FK^R4)A2=A)_A 4%0QZ*7X&
MJT$%0M#D#=IL%*V2U 0=)?HG',U]I%\,28KADH:N0PUGEL&%_IQIXI0'2U$@
M:I0G&"5K E'+/UG4$%YPFA35M&KDH-BGC'1/O@'ZU=!G$'9%(0M':/=LWNIG
MZ'WW.P.RZ:R[QL3WCV1P'!AS6E5CTHF!K*I13B*O5>CN<!3QSC.J=:U&*V]*
MZ2XQ*!S?>3,4^_E]\)>(1>*_G#$B?VBN-&NR>E)BS&'6B]V.D.?=,8KX8-0R
M(+GYQF!H < "EL&>T;$P5[#9]>N&D3,\(8UK=R/EJ8FVAV M&M3:42<EI(\)
MAMAJ1?H2KBE1=0[V\JVEZ#YZ&])NI-]'?;>W0M@7??;Y)&RLC1(WRP8#<7P&
M-B<AA'ZE/X\F0E(N0$KN?@FV!&:"G[2@;E82P;9=[@2O#!X:HUCBB"/_@TU$
M.N&"2%*!7C)!4=JYR+&U88NX?FWR#W>6(%Q[8_U7XXJZ=Y3<EKM#.M03L54-
M4U>G 5P/F483:6.OR%I34MV0++!>'94UX.$ '5;3!2H'187C-J,ZG_,/KLQ
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M/1O/3\(*E2+;7YE]3^1L)/T5LZRTM*37S\84>.]UE5,8I$(@;$D?XRFEY<9
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M!&9<@#3:@/]/OQH]6O*_UJ,5+?)6#_S!R_>O__D"?_C;Z4]O7_Q_4$L#!!0
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M<MHP$'WO3/]!]6O&%H:2!@+)4#)IF2%I)C1IIB\=8<N@B2RYD@SF[ROYQL5
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M3=WC5E$0O=_ES"2AU**FV#$6"TZ3*,D2MOY%GGR*!-M:91.Y @(VJ&EH*X)
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MDS4&DA-VJEU#T6'9Y,,B#0H5V!\X9E0AZ!#C.J-EGN),I><7FWS_5_*#I96
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M8V]U<G1S:61E+FAT;5!+ 0(4 Q0    (  B(#U>0>U73,UH  /:> 0 <
M          "  5X?  !E83$X,S8Q,V5X,3 M,5]C;W5R='-I9&4N:'1M4$L!
M A0#%     @ "(@/5XK;Q4 A+0  +^X  !P              ( !RWD  &5A
M,3@S-C$S97@Q,"TR7V-O=7)T<VED92YH=&U02P$"% ,4    "  (B ]778*L
M(BX#  #^"P  $0              @ $FIP  <&]D8RTR,#(S,#@P.2YX<V10
M2P$"% ,4    "  (B ]7E86!@?X*  " A@  %0              @ &#J@
M<&]D8RTR,#(S,#@P.5]L86(N>&UL4$L! A0#%     @ "(@/5\"#0AY=!P
MYU<  !4              ( !M+4  '!O9&,M,C R,S X,#E?<')E+GAM;%!+
4!08     !@ & * !  !$O0     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
